{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:42:55Z","timestamp":1784860975812,"version":"3.55.0"},"reference-count":275,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,26]]},"DOI":"10.7759\/cureus.57008","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T06:31:35Z","timestamp":1711521095000},"source":"Crossref","is-referenced-by-count":1,"title":["Impacts of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review"],"prefix":"10.7759","author":[{"given":"Annelise","family":"Bocquet-Gar\u00e7on","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27132","article-title":"Molecular biology of the SARs-CoV-2 spike protein: a review of current knowledge","volume":"93","author":"Zhu C","year":"2021","unstructured":"Zhu C, He G, Yin Q, Zeng L, Ye X, Shi Y, Xu W. Molecular biology of the SARs-CoV-2 spike protein: a review of current knowledge. J Med Virol. 2021, 93:5729-41. 10.1002\/jmv.27132","journal-title":"J Med Virol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.1c00433","article-title":"Structure and mutations of SARS-CoV-2 spike protein: a focused overview","volume":"8","author":"Mehra R","year":"2022","unstructured":"Mehra R, Kepp KP. Structure and mutations of SARS-CoV-2 spike protein: a focused overview. ACS Infect Dis. 2022, 8:29-58. 10.1021\/acsinfecdis.1c00433","journal-title":"ACS Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-021-00908-w","article-title":"The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets","volume":"6","author":"Peacock TP","year":"2021","unstructured":"Peacock TP, Goldhill DH, Zhou J, et al.. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat Microbiol. 2021, 6:899-909. 10.1038\/s41564-021-00908-w","journal-title":"Nat Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-022-00419-w","article-title":"Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies","volume":"8","author":"Zhao MM","year":"2022","unstructured":"Zhao MM, Zhu Y, Zhang L, et al.. Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies. Cell Discov. 2022, 8:53. 10.1038\/s41421-022-00419-w","journal-title":"Cell Discov"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-07700-x","article-title":"SARS-CoV-2 cell entry beyond the ACE2 receptor","volume":"49","author":"Alipoor SD","year":"2022","unstructured":"Alipoor SD, Mirsaeidi M. SARS-CoV-2 cell entry beyond the ACE2 receptor. Mol Biol Rep. 2022, 49:10715-27. 10.1007\/s11033-022-07700-x","journal-title":"Mol Biol Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd5223","article-title":"In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges","volume":"370","author":"Turo\u0148ov\u00e1 B","year":"2020","unstructured":"Turo\u0148ov\u00e1 B, Sikora M, Sch\u00fcrmann C, et al.. In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges. Science. 2020, 370:203-8. 10.1126\/science.abd5223","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey WT","year":"2021","unstructured":"Harvey WT, Carabelli AM, Jackson B, et al.. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021, 19:409-24. 10.1038\/s41579-021-00573-0","journal-title":"Nat Rev Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/v14081603","article-title":"Immune escape associated with RBD omicron mutations and SARS-CoV-2 evolution dynamics","volume":"14","author":"Kudriavtsev AV","year":"2022","unstructured":"Kudriavtsev AV, Vakhrusheva AV, Novos\u0435letsky VN, Bozdaganyan ME, Shaitan KV, Kirpichnikov MP, Sokolova OS. Immune escape associated with RBD omicron mutations and SARS-CoV-2 evolution dynamics. Viruses. 2022, 14:10.3390\/v14081603","journal-title":"Viruses"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10020280","article-title":"Prion-like domains in spike protein of SARS-CoV-2 differ across its variants and enable changes in affinity to ACE2","volume":"10","author":"Tetz G","year":"2022","unstructured":"Tetz G, Tetz V. Prion-like domains in spike protein of SARS-CoV-2 differ across its variants and enable changes in affinity to ACE2. Microorganisms. 2022, 10:10.3390\/microorganisms10020280","journal-title":"Microorganisms"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031923","article-title":"Convergent evolution dynamics of SARS-CoV-2 and HIV surface envelope glycoproteins driven by host cell surface receptors and lipid rafts: lessons for the future","volume":"24","author":"Fantini J","year":"2023","unstructured":"Fantini J, Chahinian H, Yahi N. Convergent evolution dynamics of SARS-CoV-2 and HIV surface envelope glycoproteins driven by host cell surface receptors and lipid rafts: lessons for the future. Int J Mol Sci. 2023, 24:10.3390\/ijms24031923","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4073","article-title":"Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V","volume":"30","author":"Bollavaram K","year":"2021","unstructured":"Bollavaram K, Leeman TH, Lee MW, et al.. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V. Protein Sci. 2021, 30:1131-43. 10.1002\/pro.4073","journal-title":"Protein Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.2c03925","article-title":"Amyloidogenesis of SARS-CoV-2 spike protein","volume":"144","author":"Nystr\u00f6m S","year":"2022","unstructured":"Nystr\u00f6m S, Hammarstr\u00f6m P. Amyloidogenesis of SARS-CoV-2 spike protein. J Am Chem Soc. 2022, 144:8945-50. 10.1021\/jacs.2c03925","journal-title":"J Am Chem Soc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00152.2022","article-title":"Competitive cleavage of SARS-CoV-2 spike protein and epithelial sodium channel by plasmin as a potential mechanism for COVID-19 infection","volume":"323","author":"Hou Y","year":"2022","unstructured":"Hou Y, Yu T, Wang T, Ding Y, Cui Y, Nie H. Competitive cleavage of SARS-CoV-2 spike protein and epithelial sodium channel by plasmin as a potential mechanism for COVID-19 infection. Am J Physiol Lung Cell Mol Physiol. 2022, 323:L569-77. 10.1152\/ajplung.00152.2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-021-05343-0","article-title":"Trypsin enhances SARS-CoV-2 infection by facilitating viral entry","volume":"167","author":"Kim Y","year":"2022","unstructured":"Kim Y, Jang G, Lee D, Kim N, Seon JW, Kim YH, Lee C. Trypsin enhances SARS-CoV-2 infection by facilitating viral entry. Arch Virol. 2022, 167:441-58. 10.1007\/s00705-021-05343-0","journal-title":"Arch Virol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc3582","article-title":"TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes","volume":"5","author":"Zang R","year":"2020","unstructured":"Zang R, Gomez Castro MF, McCune BT, et al.. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020, 5:10.1126\/sciimmunol.abc3582","journal-title":"Sci Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/v13030384","article-title":"TMPRSS11D and TMPRSS13 activate the SARS-CoV-2 spike protein","volume":"13","author":"Kishimoto M","year":"2021","unstructured":"Kishimoto M, Uemura K, Sanaki T, et al.. TMPRSS11D and TMPRSS13 activate the SARS-CoV-2 spike protein. Viruses. 2021, 13:10.3390\/v13030384","journal-title":"Viruses"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25990","article-title":"Asymptomatic cases with SARS-CoV-2 infection","volume":"92","author":"Wang Y","year":"2020","unstructured":"Wang Y, Kang H, Liu X, Tong Z. Asymptomatic cases with SARS-CoV-2 infection. J Med Virol. 2020, 92:1401-3. 10.1002\/jmv.25990","journal-title":"J Med Virol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.582932","article-title":"Coronavirus disease (COVID-19): comprehensive review of clinical presentation","volume":"8","author":"Mehta OP","year":"2020","unstructured":"Mehta OP, Bhandari P, Raut A, Kacimi SE, Huy NT. Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Front Public Health. 2020, 8:582932. 10.3389\/fpubh.2020.582932","journal-title":"Front Public Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00311-1","article-title":"The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies","volume":"27","author":"Zalpoor H","year":"2022","unstructured":"Zalpoor H, Akbari A, Samei A, et al.. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Cell Mol Biol Lett. 2022, 27:10. 10.1186\/s11658-022-00311-1","journal-title":"Cell Mol Biol Lett"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjac021","article-title":"SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients","volume":"14","author":"Pontelli MC","year":"2022","unstructured":"Pontelli MC, Castro \u00cdA, Martins RB, et al.. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients. J Mol Cell Biol. 2022, 14:10.1093\/jmcb\/mjac021","journal-title":"J Mol Cell Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01202-8","article-title":"Immune determinants of COVID-19 disease presentation and severity","volume":"27","author":"Brodin P","year":"2021","unstructured":"Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021, 27:28-33. 10.1038\/s41591-020-01202-8","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149470","article-title":"Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients","volume":"52","author":"Hagemann K","year":"2022","unstructured":"Hagemann K, Riecken K, Jung JM, et al.. Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients. Eur J Immunol. 2022, 52:1297-307. 10.1002\/eji.202149470","journal-title":"Eur J Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-020-01337-3","article-title":"Inflammation triggered by SARS-CoV-2 and ACE2 augment drives multiple organ failure of severe COVID-19: molecular mechanisms and implications","volume":"44","author":"Iwasaki M","year":"2021","unstructured":"Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D. Inflammation triggered by SARS-CoV-2 and ACE2 augment drives multiple organ failure of severe COVID-19: molecular mechanisms and implications. Inflammation. 2021, 44:13-34. 10.1007\/s10753-020-01337-3","journal-title":"Inflammation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26226945","article-title":"The renin-angiotensin system: a key role in SARS-CoV-2-induced COVID-19","volume":"26","author":"El-Arif G","year":"2021","unstructured":"El-Arif G, Farhat A, Khazaal S, et al.. The renin-angiotensin system: a key role in SARS-CoV-2-induced COVID-19. Molecules. 2021, 26:10.3390\/molecules26226945","journal-title":"Molecules"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: the first line of defense against SARS-CoV-2","volume":"23","author":"Diamond MS","year":"2022","unstructured":"Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol. 2022, 23:165-76. 10.1038\/s41590-021-01091-0","journal-title":"Nat Immunol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang Q","year":"2020","unstructured":"Zhang Q, Bastard P, Liu Z, et al.. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020, 370:10.1126\/science.abd4570","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01030-z","article-title":"A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection","volume":"23","author":"Andreakos E","year":"2022","unstructured":"Andreakos E, Abel L, Vinh DC, et al.. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nat Immunol. 2022, 23:159-64. 10.1038\/s41590-021-01030-z","journal-title":"Nat Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei X","year":"2020","unstructured":"Lei X, Dong X, Ma R, et al.. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020, 11:3810. 10.1038\/s41467-020-17665-9","journal-title":"Nat Commun"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203760119","article-title":"Interferon resistance of emerging SARS-CoV-2 variants","volume":"119","author":"Guo K","year":"2022","unstructured":"Guo K, Barrett BS, Morrison JH, et al.. Interferon resistance of emerging SARS-CoV-2 variants. Proc Natl Acad Sci U S A. 2022, 119:e2203760119. 10.1073\/pnas.2203760119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki R","year":"2021","unstructured":"Karki R, Sharma BR, Tuladhar S, et al.. Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021, 184:149-168.e17. 10.1016\/j.cell.2020.11.025","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-00936-x","article-title":"T cell apoptosis characterizes severe Covid-19 disease","volume":"29","author":"Andr\u00e9 S","year":"2022","unstructured":"Andr\u00e9 S, Picard M, Cezar R, et al.. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022, 29:1486-99. 10.1038\/s41418-022-00936-x","journal-title":"Cell Death Differ"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam PS","year":"2021","unstructured":"Arunachalam PS, Scott MK, Hagan T, et al.. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021, 596:410-6. 10.1038\/s41586-021-03791-x","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi C","year":"2021","unstructured":"Bergamaschi C, Terpos E, Rosati M, et al.. Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep. 2021, 36:109504. 10.1016\/j.celrep.2021.109504","journal-title":"Cell Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li C","year":"2022","unstructured":"Li C, Lee A, Grigoryan L, et al.. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat Immunol. 2022, 23:543-55. 10.1038\/s41590-022-01163-9","journal-title":"Nat Immunol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Swank Z","year":"2023","unstructured":"Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, Walt DR. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023, 76:e487-90. 10.1093\/cid\/ciac722","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi N","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018, 17:261-79. 10.1038\/nrd.2017.243","journal-title":"Nat Rev Drug Discov"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103699","article-title":"Current and future nanoparticle vaccines for COVID-19","volume":"74","author":"Vu MN","year":"2021","unstructured":"Vu MN, Kelly HG, Kent SJ, Wheatley AK. Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021, 74:103699. 10.1016\/j.ebiom.2021.103699","journal-title":"EBioMedicine"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/v13010109","article-title":"Domains and functions of spike protein in Sars-Cov-2 in the context of vaccine design","volume":"13","author":"Xia X","year":"2021","unstructured":"Xia X. Domains and functions of spike protein in Sars-Cov-2 in the context of vaccine design. Viruses. 2021, 13:10.3390\/v13010109","journal-title":"Viruses"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel AB","year":"2021","unstructured":"Vogel AB, Kanevsky I, Che Y, et al.. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021, 592:283-9. 10.1038\/s41586-021-03275-y","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701501","article-title":"SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants","volume":"12","author":"Mart\u00ednez-Flores D","year":"2021","unstructured":"Mart\u00ednez-Flores D, Zepeda-Cervantes J, Cruz-Res\u00e9ndiz A, Aguirre-Sampieri S, Sampieri A, Vaca L. SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants. Front Immunol. 2021, 12:701501. 10.3389\/fimmu.2021.701501","journal-title":"Front Immunol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660198","article-title":"Enhancing the prefusion conformational stability of SARS-CoV-2 spike protein through structure-guided design","volume":"12","author":"Riley TP","year":"2021","unstructured":"Riley TP, Chou HT, Hu R, et al.. Enhancing the prefusion conformational stability of SARS-CoV-2 spike protein through structure-guided design. Front Immunol. 2021, 12:660198. 10.3389\/fimmu.2021.660198","journal-title":"Front Immunol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.09.057","article-title":"Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation","volume":"40","author":"Deng T","year":"2022","unstructured":"Deng T, Li T, Chen G, et al.. Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation. Vaccine. 2022, 40:6839-48. 10.1016\/j.vaccine.2022.09.057","journal-title":"Vaccine"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adf1421","article-title":"SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines","volume":"7","author":"Bowen JE","year":"2022","unstructured":"Bowen JE, Park YJ, Stewart C, et al.. SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines. Sci Immunol. 2022, 7:eadf1421. 10.1126\/sciimmunol.adf1421","journal-title":"Sci Immunol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang Z","year":"2021","unstructured":"Wang Z, Schmidt F, Weisblum Y, et al.. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021, 592:616-22. 10.1038\/s41586-021-03324-6","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111496","article-title":"SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations","volume":"41","author":"Anderson EM","year":"2022","unstructured":"Anderson EM, Li SH, Awofolaju M, et al.. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations. Cell Rep. 2022, 41:111496. 10.1016\/j.celrep.2022.111496","journal-title":"Cell Rep"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121673","article-title":"Dissecting antibodies with regards to linear and conformational epitopes","volume":"10","author":"Forsstr\u00f6m B","year":"2015","unstructured":"Forsstr\u00f6m B, Axn\u00e4s BB, Rockberg J, Danielsson H, Bohlin A, Uhlen M. Dissecting antibodies with regards to linear and conformational epitopes. PLoS One. 2015, 10:e0121673. 10.1371\/journal.pone.0121673","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq3773","article-title":"Broadly neutralizing antibodies target the coronavirus fusion peptide","volume":"377","author":"Dacon C","year":"2022","unstructured":"Dacon C, Tucker C, Peng L, et al.. Broadly neutralizing antibodies target the coronavirus fusion peptide. Science. 2022, 377:728-35. 10.1126\/science.abq3773","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/v14030640","article-title":"Mutations and evolution of the SARS-CoV-2 spike protein","volume":"14","author":"Magazine N","year":"2022","unstructured":"Magazine N, Zhang T, Wu Y, McGee MC, Veggiani G, Huang W. Mutations and evolution of the SARS-CoV-2 spike protein. Viruses. 2022, 14:10.3390\/v14030640","journal-title":"Viruses"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00841-7","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli AM","year":"2023","unstructured":"Carabelli AM, Peacock TP, Thorne LG, et al.. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023, 21:162-77. 10.1038\/s41579-022-00841-7","journal-title":"Nat Rev Microbiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/v14071415","article-title":"Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins","volume":"14","author":"Nunez-Castilla J","year":"2022","unstructured":"Nunez-Castilla J, Stebliankin V, Baral P, et al.. Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins. Viruses. 2022, 14:10.3390\/v14071415","journal-title":"Viruses"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.06.041","article-title":"Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses","volume":"19","author":"Beaudoin CA","year":"2021","unstructured":"Beaudoin CA, Jamasb AR, Alsulami AF, et al.. Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses. Comput Struct Biotechnol J. 2021, 19:3938-53. 10.1016\/j.csbj.2021.06.041","journal-title":"Comput Struct Biotechnol J"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7021e3","article-title":"COVID-19 vaccine breakthrough infections reported to CDC - United States, January 1-April 30, 2021","year":"2021","unstructured":"COVID-19 vaccine breakthrough infections reported to CDC - United States, January 1-April 30, 2021. 2021, 70.792-3. 10.15585\/mmwr.mm7021e3"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19993-w","article-title":"Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells","volume":"12","author":"Shimizu J","year":"2022","unstructured":"Shimizu J, Sasaki T, Koketsu R, et al.. Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells. Sci Rep. 2022, 12:15612. 10.1038\/s41598-022-19993-w","journal-title":"Sci Rep"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1101\/2023.02.20.529249","article-title":"Antibody-mediated cell entry of SARS-CoV-2 [PREPRINT]","author":"Md Golam Kibria","year":"2023","unstructured":"Md Golam Kibria, Christy L. Lavine, Weichun Tang, et al.. Antibody-mediated cell entry of SARS-CoV-2 [PREPRINT]. bioRxiv. 2023, 10.1101\/2023.02.20.529249","journal-title":"bioRxiv"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens2020232","article-title":"Host-viral interactions: role of pattern recognition receptors (PRRs) in human pneumovirus infections","volume":"2","author":"Kolli D","year":"2013","unstructured":"Kolli D, Velayutham TS, Casola A. Host-viral interactions: role of pattern recognition receptors (PRRs) in human pneumovirus infections. Pathogens. 2013, 2:232-63. 10.3390\/pathogens2020232","journal-title":"Pathogens"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li D","year":"2021","unstructured":"Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021, 6:291. 10.1038\/s41392-021-00687-0","journal-title":"Signal Transduct Target Ther"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki A","year":"2015","unstructured":"Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol. 2015, 16:343-53. 10.1038\/ni.3123","journal-title":"Nat Immunol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2021.11.002","article-title":"Host cell-intrinsic innate immune recognition of SARS-CoV-2","volume":"52","author":"Madden EA","year":"2022","unstructured":"Madden EA, Diamond MS. Host cell-intrinsic innate immune recognition of SARS-CoV-2. Curr Opin Virol. 2022, 52:30-8. 10.1016\/j.coviro.2021.11.002","journal-title":"Curr Opin Virol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3390\/v14071349","article-title":"Coronaviral infection and interferon response: the virus-host arms race and COVID-19","volume":"14","author":"Liu Q","year":"2022","unstructured":"Liu Q, Chi S, Dmytruk K, Dmytruk O, Tan S. Coronaviral infection and interferon response: the virus-host arms race and COVID-19. Viruses. 2022, 14:10.3390\/v14071349","journal-title":"Viruses"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song P","year":"2020","unstructured":"Song P, Li W, Xie J, Hou Y, You C. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta. 2020, 509:280-7. 10.1016\/j.cca.2020.06.017","journal-title":"Clin Chim Acta"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu B","year":"2021","unstructured":"Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021, 93:250-6. 10.1002\/jmv.26232","journal-title":"J Med Virol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb S","year":"2022","unstructured":"Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, et al.. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J. 2022, 19:92. 10.1186\/s12985-022-01814-1","journal-title":"Virol J"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng M","year":"2021","unstructured":"Zheng M, Karki R, Williams EP, et al.. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021, 22:829-38. 10.1038\/s41590-021-00937-x","journal-title":"Nat Immunol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3390\/v14050999","article-title":"SARS-CoV-2 envelope (E) protein binds and activates TLR2 pathway: a novel molecular target for COVID-19 interventions","volume":"14","author":"Plan\u00e8s R","year":"2022","unstructured":"Plan\u00e8s R, Bert JB, Tairi S, BenMohamed L, Bahraoui E. SARS-CoV-2 envelope (E) protein binds and activates TLR2 pathway: a novel molecular target for COVID-19 interventions. Viruses. 2022, 14:10.3390\/v14050999","journal-title":"Viruses"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01396-21","article-title":"Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by simvastatin","volume":"95","author":"Qian Y","year":"2021","unstructured":"Qian Y, Lei T, Patel PS, et al.. Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by simvastatin. J Virol. 2021, 95:e0139621. 10.1128\/JVI.01396-21","journal-title":"J Virol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68563","article-title":"SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway","volume":"10","author":"Khan S","year":"2021","unstructured":"Khan S, Shafiei MS, Longoria C, Schoggins JW, Savani RC, Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway. Elife. 2021, 10:10.7554\/eLife.68563","journal-title":"Elife"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao Y","year":"2021","unstructured":"Zhao Y, Kuang M, Li J, et al.. SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. 2021, 31:818-20. 10.1038\/s41422-021-00495-9","journal-title":"Cell Res"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06187","article-title":"SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages","volume":"7","author":"Shirato K","year":"2021","unstructured":"Shirato K, Kizaki T. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon. 2021, 7:e06187. 10.1016\/j.heliyon.2021.e06187","journal-title":"Heliyon"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112189","article-title":"SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice","volume":"42","author":"Fontes-Dantas FL","year":"2023","unstructured":"Fontes-Dantas FL, Fernandes GG, Gutman EG, et al.. SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep. 2023, 42:112189. 10.1016\/j.celrep.2023.112189","journal-title":"Cell Rep"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation","volume":"2021","author":"Aboudounya MM","year":"2021","unstructured":"Aboudounya MM, Heads RJ. COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediators Inflamm. 2021, 2021:8874339. 10.1155\/2021\/8874339","journal-title":"Mediators Inflamm"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 Is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler CG","year":"2020","unstructured":"Ziegler CG, Allon SJ, Nyquist SK, et al.. SARS-CoV-2 receptor ACE2 Is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020, 181:1016-1035.e19. 10.1016\/j.cell.2020.04.035","journal-title":"Cell"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155430","article-title":"ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?","volume":"140","author":"Scagnolari C","year":"2021","unstructured":"Scagnolari C, Bitossi C, Viscido A, et al.. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?. Cytokine. 2021, 140:155430. 10.1016\/j.cyto.2021.155430","journal-title":"Cytokine"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0185-z","article-title":"A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2","volume":"5","author":"Su S","year":"2020","unstructured":"Su S, Jiang S. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2. Signal Transduct Target Ther. 2020, 5:71. 10.1038\/s41392-020-0185-z","journal-title":"Signal Transduct Target Ther"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9010093","article-title":"SARS-CoV-2 entry genes expression in relation with interferon response in cystic fibrosis patients","volume":"9","author":"Bitossi C","year":"2021","unstructured":"Bitossi C, Frasca F, Viscido A, et al.. SARS-CoV-2 entry genes expression in relation with interferon response in cystic fibrosis patients. Microorganisms. 2021, 9:10.3390\/microorganisms9010093","journal-title":"Microorganisms"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1038\/srep20158","article-title":"Amplified RLR signaling activation through an interferon-stimulated gene-endoplasmic reticulum stress-mitochondrial calcium uniporter protein loop","volume":"6","author":"Cheng J","year":"2016","unstructured":"Cheng J, Liao Y, Zhou L, Peng S, Chen H, Yuan Z. Amplified RLR signaling activation through an interferon-stimulated gene-endoplasmic reticulum stress-mitochondrial calcium uniporter protein loop. Sci Rep. 2016, 6:20158. 10.1038\/srep20158","journal-title":"Sci Rep"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2019.05.001","article-title":"Type I interferon signaling, regulation and gene stimulation in chronic virus infection","volume":"43","author":"Lukhele S","year":"2019","unstructured":"Lukhele S, Boukhaled GM, Brooks DG. Type I interferon signaling, regulation and gene stimulation in chronic virus infection. Semin Immunol. 2019, 43:101277. 10.1016\/j.smim.2019.05.001","journal-title":"Semin Immunol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.771555","article-title":"Large screening identifies ACE2 positively correlates with NF-\u03baB signaling activity and targeting NF-\u03baB signaling drugs suppress ACE2 levels","volume":"12","author":"Yan M","year":"2021","unstructured":"Yan M, Dong Y, Bo X, Cheng Y, Cheng J. Large screening identifies ACE2 positively correlates with NF-\u03baB signaling activity and targeting NF-\u03baB signaling drugs suppress ACE2 levels. Front Pharmacol. 2021, 12:771555. 10.3389\/fphar.2021.771555","journal-title":"Front Pharmacol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-022-00453-8","article-title":"Surface translocation of ACE2 and TMPRSS2 upon TLR4\/7\/8 activation is required for SARS-CoV-2 infection in circulating monocytes","volume":"8","author":"Yao Y","year":"2022","unstructured":"Yao Y, Subedi K, Liu T, et al.. Surface translocation of ACE2 and TMPRSS2 upon TLR4\/7\/8 activation is required for SARS-CoV-2 infection in circulating monocytes. Cell Discov. 2022, 8:89. 10.1038\/s41421-022-00453-8","journal-title":"Cell Discov"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2020.106826","article-title":"A new storm on the horizon in COVID-19: bradykinin-induced vascular complications","volume":"137","author":"McCarthy CG","year":"2021","unstructured":"McCarthy CG, Wilczynski S, Wenceslau CF, Webb RC. A new storm on the horizon in COVID-19: bradykinin-induced vascular complications. Vascul Pharmacol. 2021, 137:106826. 10.1016\/j.vph.2020.106826","journal-title":"Vascul Pharmacol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.59177","article-title":"A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm","volume":"9","author":"Garvin MR","year":"2020","unstructured":"Garvin MR, Alvarez C, Miller JI, et al.. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife. 2020, 9:10.7554\/eLife.59177","journal-title":"Elife"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.03.017","article-title":"The interplay between angiotensin II, TLR4 and hypertension","volume":"120","author":"Biancardi VC","year":"2017","unstructured":"Biancardi VC, Bomfim GF, Reis WL, Al-Gassimi S, Nunes KP. The interplay between angiotensin II, TLR4 and hypertension. Pharmacol Res. 2017, 120:88-96. 10.1016\/j.phrs.2017.03.017","journal-title":"Pharmacol Res"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjaa067","article-title":"SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity","volume":"12","author":"Petruk G","year":"2020","unstructured":"Petruk G, Puthia M, Petrlova J, et al.. SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity. J Mol Cell Biol. 2020, 12:916-32. 10.1093\/jmcb\/mjaa067","journal-title":"J Mol Cell Biol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14490","article-title":"SARS-CoV-2 spike protein aggregation is triggered by bacterial lipopolysaccharide","volume":"596","author":"Petrlova J","year":"2022","unstructured":"Petrlova J, Samsudin F, Bond PJ, Schmidtchen A. SARS-CoV-2 spike protein aggregation is triggered by bacterial lipopolysaccharide. FEBS Lett. 2022, 596:2566-75. 10.1002\/1873-3468.14490","journal-title":"FEBS Lett"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjac058","article-title":"SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade","volume":"14","author":"Samsudin F","year":"2023","unstructured":"Samsudin F, Raghuvamsi P, Petruk G, et al.. SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade. J Mol Cell Biol. 2023, 14:10.1093\/jmcb\/mjac058","journal-title":"J Mol Cell Biol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c10658","article-title":"Amyloid and hydrogel formation of a peptide sequence from a coronavirus spike protein","volume":"16","author":"Castelletto V","year":"2022","unstructured":"Castelletto V, Hamley IW. Amyloid and hydrogel formation of a peptide sequence from a coronavirus spike protein. ACS Nano. 2022, 16:1857-67. 10.1021\/acsnano.1c10658","journal-title":"ACS Nano"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.12.007","article-title":"SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties","volume":"100","author":"Frank MG","year":"2022","unstructured":"Frank MG, Nguyen KH, Ball JB, et al.. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties. Brain Behav Immun. 2022, 100:267-77. 10.1016\/j.bbi.2021.12.007","journal-title":"Brain Behav Immun"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32361","article-title":"Mitogen activated protein kinase (MAPK) activation, p53, and autophagy inhibition characterize the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein induced neurotoxicity","volume":"14","author":"Kyriakopoulos AM","year":"2022","unstructured":"Kyriakopoulos AM, Nigh G, McCullough PA, Seneff S. Mitogen activated protein kinase (MAPK) activation, p53, and autophagy inhibition characterize the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein induced neurotoxicity. Cureus. 2022, 14:e32361. 10.7759\/cureus.32361","journal-title":"Cureus"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-022-00458-3","article-title":"SARS-CoV-2 Spike protein S2 subunit modulates \u03b3-secretase and enhances amyloid-\u03b2 production in COVID-19 neuropathy","volume":"8","author":"Ma G","year":"2022","unstructured":"Ma G, Zhang DF, Zou QC, et al.. SARS-CoV-2 Spike protein S2 subunit modulates \u03b3-secretase and enhances amyloid-\u03b2 production in COVID-19 neuropathy. Cell Discov. 2022, 8:99. 10.1038\/s41421-022-00458-3","journal-title":"Cell Discov"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2022.152057","article-title":"The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection","volume":"61","author":"Nuovo GJ","year":"2022","unstructured":"Nuovo GJ, Suster D, Sawant D, Mishra A, Michaille JJ, Tili E. The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection. Ann Diagn Pathol. 2022, 61:152057. 10.1016\/j.anndiagpath.2022.152057","journal-title":"Ann Diagn Pathol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.03.100","article-title":"SARS-CoV-2 spike protein interactions with amyloidogenic proteins: potential clues to neurodegeneration","volume":"554","author":"Idrees D","year":"2021","unstructured":"Idrees D, Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: potential clues to neurodegeneration. Biochem Biophys Res Commun. 2021, 554:94-8. 10.1016\/j.bbrc.2021.03.100","journal-title":"Biochem Biophys Res Commun"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158226","article-title":"The Effects of A\u03b2(1-42) binding to the SARS-CoV-2 Spike protein S1 subunit and angiotensin-converting enzyme 2","volume":"22","author":"Hsu JT","year":"2021","unstructured":"Hsu JT, Tien CF, Yu GY, et al.. The Effects of A\u03b2(1-42) binding to the SARS-CoV-2 Spike protein S1 subunit and angiotensin-converting enzyme 2. Int J Mol Sci. 2021, 22:10.3390\/ijms22158226","journal-title":"Int J Mol Sci"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102260","article-title":"Genomic deletion of TLR2 induces aggravated white matter damage and deteriorated neurobehavioral functions in mouse models of Alzheimer's disease","volume":"11","author":"Zhou C","year":"2019","unstructured":"Zhou C, Sun X, Hu Y, et al.. Genomic deletion of TLR2 induces aggravated white matter damage and deteriorated neurobehavioral functions in mouse models of Alzheimer's disease. Aging (Albany NY). 2019, 11:7257-73. 10.18632\/aging.102260","journal-title":"Aging (Albany NY)"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-0792-9","article-title":"Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat\u00a0neuronal cell death","volume":"3","author":"Hughes C","year":"2020","unstructured":"Hughes C, Choi ML, Yi JH, et al.. Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat\u00a0neuronal cell death. Commun Biol. 2020, 3:79. 10.1038\/s42003-020-0792-9","journal-title":"Commun Biol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2023.111015","article-title":"Potential health risks of mRNA-based vaccine therapy: A hypothesis","volume":"171","author":"Acevedo-Whitehouse K","year":"2023","unstructured":"Acevedo-Whitehouse K, Bruno R. Potential health risks of mRNA-based vaccine therapy: A hypothesis. Med Hypotheses. 2023, 171:111015. 10.1016\/j.mehy.2023.111015","journal-title":"Med Hypotheses"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-021-00884-1","article-title":"ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity","volume":"6","author":"Liu G","year":"2021","unstructured":"Liu G, Lee JH, Parker ZM, et al.. ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity. Nat Microbiol. 2021, 6:467-78. 10.1038\/s41564-021-00884-1","journal-title":"Nat Microbiol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0020-5","article-title":"ISG15 in antiviral immunity and beyond","volume":"16","author":"Perng YC","year":"2018","unstructured":"Perng YC, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol. 2018, 16:423-39. 10.1038\/s41579-018-0020-5","journal-title":"Nat Rev Microbiol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3390\/v13061102","article-title":"HERC5 and the ISGylation pathway: critical modulators of the antiviral immune response","volume":"13","author":"Mathieu NA","year":"2021","unstructured":"Mathieu NA, Paparisto E, Barr SD, Spratt DE. HERC5 and the ISGylation pathway: critical modulators of the antiviral immune response. Viruses. 2021, 13:10.3390\/v13061102","journal-title":"Viruses"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1038\/nature13801","article-title":"Human intracellular ISG15 prevents interferon-\u03b1\/\u03b2 over-amplification and auto-inflammation","volume":"517","author":"Zhang X","year":"2015","unstructured":"Zhang X, Bogunovic D, Payelle-Brogard B, et al.. Human intracellular ISG15 prevents interferon-\u03b1\/\u03b2 over-amplification and auto-inflammation. Nature. 2015, 517:89-93. 10.1038\/nature13801","journal-title":"Nature"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180250","article-title":"USP18 - a multifunctional component in the interferon response","volume":"38","author":"Basters A","year":"2018","unstructured":"Basters A, Knobeloch KP, Fritz G. USP18 - a multifunctional component in the interferon response. Biosci Rep. 2018, 38:10.1042\/BSR20180250","journal-title":"Biosci Rep"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12513","article-title":"Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification","volume":"7","author":"Park JH","year":"2016","unstructured":"Park JH, Yang SW, Park JM, et al.. Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification. Nat Commun. 2016, 7:12513. 10.1038\/ncomms12513","journal-title":"Nat Commun"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.10.003","article-title":"Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor","volume":"68(3)","author":"Swaim CD","year":"2017","unstructured":"Swaim CD, Scott AF, Canadeo LA, Huibregtse JM. Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor. Mol Cell. 2017, 68(3):581-590.e5. 10.1016\/j.molcel.2017.10.003","journal-title":"Mol Cell"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1111\/1348-0421.13043","article-title":"Comparison of cytokine production in mice inoculated with messenger RNA vaccines BNT162b2 and mRNA-1273","volume":"67","author":"Nakayama T","year":"2023","unstructured":"Nakayama T, Sawada A, Ito T. Comparison of cytokine production in mice inoculated with messenger RNA vaccines BNT162b2 and mRNA-1273. Microbiol Immunol. 2023, 67:120-8. 10.1111\/1348-0421.13043","journal-title":"Microbiol Immunol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00439-3","article-title":"Circulating extracellular vesicle microRNAs associated with adverse reactions, proinflammatory cytokine, and antibody production after COVID-19 vaccination","volume":"7","author":"Miyashita Y","year":"2022","unstructured":"Miyashita Y, Yoshida T, Takagi Y, et al.. Circulating extracellular vesicle microRNAs associated with adverse reactions, proinflammatory cytokine, and antibody production after COVID-19 vaccination. NPJ Vaccines. 2022, 7:16. 10.1038\/s41541-022-00439-3","journal-title":"NPJ Vaccines"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.3201\/eid2711.211612","article-title":"Fatal multisystem inflammatory syndrome in adult after SARS-CoV-2 natural infection and COVID-19 vaccination","volume":"27","author":"Grome HN","year":"2021","unstructured":"Grome HN, Threlkeld M, Threlkeld S, et al.. Fatal multisystem inflammatory syndrome in adult after SARS-CoV-2 natural infection and COVID-19 vaccination. Emerg Infect Dis. 2021, 27:2914-8. 10.3201\/eid2711.211612","journal-title":"Emerg Infect Dis"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243888","article-title":"Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V)","volume":"14","author":"Nune A","year":"2021","unstructured":"Nune A, Iyengar KP, Goddard C, Ahmed AE. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V). BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-243888","journal-title":"BMJ Case Rep"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.3201\/eid2804.212585","article-title":"Multisystem inflammatory syndrome in adult after first dose of mRNA vaccine","volume":"28","author":"Miyazato Y","year":"2022","unstructured":"Miyazato Y, Yamamoto K, Yamada G, et al.. Multisystem inflammatory syndrome in adult after first dose of mRNA vaccine. Emerg Infect Dis. 2022, 28:870-2. 10.3201\/eid2804.212585","journal-title":"Emerg Infect Dis"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003442","article-title":"Multisystem inflammatory syndrome in a 12-year-old boy after mRNA-SARS-CoV-2 vaccination","volume":"41","author":"Abdelgalil AA","year":"2022","unstructured":"Abdelgalil AA, Saeedi FA. Multisystem inflammatory syndrome in a 12-year-old boy after mRNA-SARS-CoV-2 vaccination. Pediatr Infect Dis J. 2022, 41:e93-4. 10.1097\/INF.0000000000003442","journal-title":"Pediatr Infect Dis J"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003432","article-title":"A case of multisystem inflammatory syndrome in a 12-year-old male after COVID-19 mRNA vaccine","volume":"41","author":"Yal\u00e7inkaya R","year":"2022","unstructured":"Yal\u00e7inkaya R, \u00d6z FN, Polat M, et al.. A case of multisystem inflammatory syndrome in a 12-year-old male after COVID-19 mRNA vaccine. Pediatr Infect Dis J. 2022, 41:e87-9. 10.1097\/INF.0000000000003432","journal-title":"Pediatr Infect Dis J"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4396368","article-title":"The CXCL10\/CXCR3 axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart","volume":"2016","author":"Altara R","year":"2016","unstructured":"Altara R, Mallat Z, Booz GW, Zouein FA. The CXCL10\/CXCR3 axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart. J Immunol Res. 2016, 2016:4396368. 10.1155\/2016\/4396368","journal-title":"J Immunol Res"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.851620","article-title":"Increased interleukin 18-dependent immune responses are associated with myopericarditis after COVID-19 mRNA vaccination","volume":"13","author":"Won T","year":"2022","unstructured":"Won T, Gilotra NA, Wood MK, et al.. Increased interleukin 18-dependent immune responses are associated with myopericarditis after COVID-19 mRNA vaccination. Front Immunol. 2022, 13:851620. 10.3389\/fimmu.2022.851620","journal-title":"Front Immunol"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.321881","article-title":"Vaccination-associated myocarditis and myocardial injury","volume":"132","author":"Altman NL","year":"2023","unstructured":"Altman NL, Berning AA, Mann SC, et al.. Vaccination-associated myocarditis and myocardial injury. Circ Res. 2023, 132:1338-57. 10.1161\/CIRCRESAHA.122.321881","journal-title":"Circ Res"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytad063","article-title":"Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report","volume":"7","author":"Fujii M","year":"2023","unstructured":"Fujii M, Toba T, Fukuyama Y, Tjan LH, Mori Y, Hirata KI. Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report. Eur Heart J Case Rep. 2023, 7:ytad063. 10.1093\/ehjcr\/ytad063","journal-title":"Eur Heart J Case Rep"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins JW","year":"2011","unstructured":"Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 2011, 1:519-25. 10.1016\/j.coviro.2011.10.008","journal-title":"Curr Opin Virol"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658428","article-title":"SARS-CoV-2 Spike protein suppresses ACE2 and type I interferon expression in primary cells from macaque lung bronchoalveolar lavage","volume":"12","author":"Sui Y","year":"2021","unstructured":"Sui Y, Li J, Venzon DJ, Berzofsky JA. SARS-CoV-2 Spike protein suppresses ACE2 and type I interferon expression in primary cells from macaque lung bronchoalveolar lavage. Front Immunol. 2021, 12:658428. 10.3389\/fimmu.2021.658428","journal-title":"Front Immunol"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.789462","article-title":"SARS-CoV-2 Spike antagonizes innate antiviral immunity by targeting interferon regulatory factor 3","volume":"11","author":"Freitas RS","year":"2021","unstructured":"Freitas RS, Crum TF, Parvatiyar K. SARS-CoV-2 Spike antagonizes innate antiviral immunity by targeting interferon regulatory factor 3. Front Cell Infect Microbiol. 2021, 11:789462. 10.3389\/fcimb.2021.789462","journal-title":"Front Cell Infect Microbiol"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103622","article-title":"Proteasome inhibitors as a possible therapy for SARS-CoV-2","volume":"21","author":"Longhitano L","year":"2020","unstructured":"Longhitano L, Tibullo D, Giallongo C, et al.. Proteasome inhibitors as a possible therapy for SARS-CoV-2. Int J Mol Sci. 2020, 21:10.3390\/ijms21103622","journal-title":"Int J Mol Sci"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21984-w","article-title":"Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses","volume":"12","author":"Shen Z","year":"2022","unstructured":"Shen Z, Halberg A, Fong JY, et al.. Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses. Sci Rep. 2022, 12:18811. 10.1038\/s41598-022-21984-w","journal-title":"Sci Rep"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1124\/pr.117.015370","article-title":"A practical review of proteasome pharmacology","volume":"71","author":"Thibaudeau TA","year":"2019","unstructured":"Thibaudeau TA, Smith DM. A practical review of proteasome pharmacology. Pharmacol Rev. 2019, 71:170-97. 10.1124\/pr.117.015370","journal-title":"Pharmacol Rev"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106267","article-title":"Syncytia formation by SARS-CoV-2-infected cells","volume":"39","author":"Buchrieser J","year":"2020","unstructured":"Buchrieser J, Dufloo J, Hubert M, et al.. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 2020, 39:e106267. 10.15252\/embj.2020106267","journal-title":"EMBO J"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00587-21","article-title":"D614G substitution of SARS-CoV-2 Spike protein increases syncytium formation and virus titer via enhanced furin-mediated spike cleavage","volume":"12","author":"Cheng YW","year":"2021","unstructured":"Cheng YW, Chao TL, Li CL, et al.. D614G substitution of SARS-CoV-2 Spike protein increases syncytium formation and virus titer via enhanced furin-mediated spike cleavage. mBio. 2021, 12:e0058721. 10.1128\/mBio.00587-21","journal-title":"mBio"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00782-3","article-title":"SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination","volume":"28","author":"Zhang Z","year":"2021","unstructured":"Zhang Z, Zheng Y, Niu Z, et al.. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Differ. 2021, 28:2765-77. 10.1038\/s41418-021-00782-3","journal-title":"Cell Death Differ"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108944","article-title":"SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation","volume":"40","author":"Rajah MM","year":"2021","unstructured":"Rajah MM, Hubert M, Bishop E, et al.. SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation. EMBO J. 2021, 40:e108944. 10.15252\/embj.2021108944","journal-title":"EMBO J"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28053","article-title":"Rapid quantitative monitoring of SARS-CoV-2 spike protein-mediated syncytia formation using split NanoLuc","volume":"94","author":"Wang H","year":"2022","unstructured":"Wang H, Guo S, Yang H. Rapid quantitative monitoring of SARS-CoV-2 spike protein-mediated syncytia formation using split NanoLuc. J Med Virol. 2022, 94:6073-7. 10.1002\/jmv.28053","journal-title":"J Med Virol"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abg8744","article-title":"SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response","volume":"15","author":"Liu X","year":"2022","unstructured":"Liu X, Wei L, Xu F, et al.. SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response. Sci Signal. 2022, 15:eabg8744. 10.1126\/scisignal.abg8744","journal-title":"Sci Signal"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24817-y","article-title":"IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro","volume":"12","author":"Prelli Bozzo C","year":"2021","unstructured":"Prelli Bozzo C, Nchioua R, Volcic M, et al.. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat Commun. 2021, 12:4584. 10.1038\/s41467-021-24817-y","journal-title":"Nat Commun"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1101\/2022.10.21.512606","article-title":"Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques","author":"Hoang TN","year":"2022","unstructured":"Hoang TN, Viox EG, Upadhyay AA, et al.. Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques. bioRxiv. 2022, 10.1101\/2022.10.21.512606","journal-title":"bioRxiv"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01250-22","article-title":"The P681H mutation in the Spike glycoprotein of the alpha variant of SARS-CoV-2 escapes IFITM  restriction and is necessary for type I interferon resistance","volume":"96","author":"Lista MJ","year":"2022","unstructured":"Lista MJ, Winstone H, Wilson HD, et al.. The P681H mutation in the Spike glycoprotein of the alpha variant of SARS-CoV-2 escapes IFITM  restriction and is necessary for type I interferon resistance. J Virol. 2022, 96:e0125022. 10.1128\/jvi.01250-22","journal-title":"J Virol"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2212577120","article-title":"SARS-CoV-2 evolution influences GBP and IFITM sensitivity","volume":"120","author":"Mesner D","year":"2023","unstructured":"Mesner D, Reuschl AK, Whelan MV, et al.. SARS-CoV-2 evolution influences GBP and IFITM sensitivity. Proc Natl Acad Sci U S A. 2023, 120:e2212577120. 10.1073\/pnas.2212577120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201745","article-title":"Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1","volume":"6","author":"Nchioua R","year":"2023","unstructured":"Nchioua R, Schundner A, Klute S, et al.. Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1. Life Sci Alliance. 2023, 6:10.26508\/lsa.202201745","journal-title":"Life Sci Alliance"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2023.199134","article-title":"SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells","volume":"332","author":"Gori Savellini G","year":"2023","unstructured":"Gori Savellini G, Anichini G, Cusi MG. SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells. Virus Res. 2023, 332:199134. 10.1016\/j.virusres.2023.199134","journal-title":"Virus Res"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1038\/ni1569","article-title":"TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta","volume":"9","author":"Kagan JC","year":"2008","unstructured":"Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol. 2008, 9:361-8. 10.1038\/ni1569","journal-title":"Nat Immunol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21690-7","article-title":"A comparative study of spike protein of SARS-CoV-2 and its variant Omicron (B.1.1.529) on some immune characteristics","volume":"12","author":"Li X","year":"2022","unstructured":"Li X, Li W, Liu Z, et al.. A comparative study of spike protein of SARS-CoV-2 and its variant Omicron (B.1.1.529) on some immune characteristics. Sci Rep. 2022, 12:17058. 10.1038\/s41598-022-21690-7","journal-title":"Sci Rep"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.04.042","article-title":"Dissociation of TRIF bias and adjuvanticity","volume":"38","author":"Richard K","year":"2020","unstructured":"Richard K, Perkins DJ, Harberts EM, et al.. Dissociation of TRIF bias and adjuvanticity. Vaccine. 2020, 38:4298-308. 10.1016\/j.vaccine.2020.04.042","journal-title":"Vaccine"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9091820","article-title":"TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection","volume":"9","author":"Bortolotti D","year":"2021","unstructured":"Bortolotti D, Gentili V, Rizzo S, et al.. TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection. Microorganisms. 2021, 9:10.3390\/microorganisms9091820","journal-title":"Microorganisms"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1007081","article-title":"Activation of TLR4 by viral glycoproteins: a double-edged sword?","volume":"13","author":"Halajian EA","year":"2022","unstructured":"Halajian EA, LeBlanc EV, Gee K, Colpitts CC. Activation of TLR4 by viral glycoproteins: a double-edged sword?. Front Microbiol. 2022, 13:1007081. 10.3389\/fmicb.2022.1007081","journal-title":"Front Microbiol"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113502","article-title":"The increased amyloidogenicity of Spike RBD and pH-dependent binding to ACE2 may contribute to the transmissibility and pathogenic properties of SARS-CoV-2 omicron as suggested by in silico study","volume":"23","author":"Aksenova AY","year":"2022","unstructured":"Aksenova AY, Likhachev IV, Grishin SY, Galzitskaya OV. The increased amyloidogenicity of Spike RBD and pH-dependent binding to ACE2 may contribute to the transmissibility and pathogenic properties of SARS-CoV-2 omicron as suggested by in silico study. Int J Mol Sci. 2022, 23:10.3390\/ijms232113502","journal-title":"Int J Mol Sci"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng B","year":"2022","unstructured":"Meng B, Abdullahi A, Ferreira IA, et al.. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022, 603:706-14. 10.1038\/s41586-022-04474-x","journal-title":"Nature"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01143-7","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","volume":"7","author":"Willett BJ","year":"2022","unstructured":"Willett BJ, Grove J, MacLean OA, et al.. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol. 2022, 7:1161-79. 10.1038\/s41564-022-01143-7","journal-title":"Nat Microbiol"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2117098","article-title":"Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2","volume":"11","author":"Hu B","year":"2022","unstructured":"Hu B, Chan JF, Liu H, et al.. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2. Emerg Microbes Infect. 2022, 11:2275-87. 10.1080\/22221751.2022.2117098","journal-title":"Emerg Microbes Infect"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.3390\/v15051129","article-title":"SARS-CoV-2 omicron specific mutations affecting infectivity, fusogenicity, and partial TMPRSS2-independency","volume":"15","author":"Strobelt R","year":"2023","unstructured":"Strobelt R, Broennimann K, Adler J, Shaul Y. SARS-CoV-2 omicron specific mutations affecting infectivity, fusogenicity, and partial TMPRSS2-independency. Viruses. 2023, 15:10.3390\/v15051129","journal-title":"Viruses"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00851-23","article-title":"SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models","volume":"97","author":"Mykytyn AZ","year":"2023","unstructured":"Mykytyn AZ, Breugem TI, Geurts MH, et al.. SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models. J Virol. 2023, 97:e0085123. 10.1128\/jvi.00851-23","journal-title":"J Virol"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.11.557206","article-title":"Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip variants [PREPRINT]","author":"Qu P","year":"2023","unstructured":"Qu P, Xu K, Faraone JN, et al.. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip variants [PREPRINT]. bioRxiv. 2023, 10.1101\/2023.09.11.557206","journal-title":"bioRxiv"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35590-x","article-title":"Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2","volume":"13","author":"Guo X","year":"2022","unstructured":"Guo X, Cao J, Cai JP, et al.. Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2. Nat Commun. 2022, 13:7907. 10.1038\/s41467-022-35590-x","journal-title":"Nat Commun"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add3867","article-title":"Altered host protease determinants for SARS-CoV-2 Omicron","volume":"9","author":"Chan JF","year":"2023","unstructured":"Chan JF, Huang X, Hu B, et al.. Altered host protease determinants for SARS-CoV-2 Omicron. Sci Adv. 2023, 9:eadd3867. 10.1126\/sciadv.add3867","journal-title":"Sci Adv"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020204","article-title":"S protein, ACE2 and host cell proteases in SARS-CoV-2 cell entry and infectivity; is soluble ACE2 a two blade sword? a narrative review","volume":"11","author":"Nejat R","year":"2023","unstructured":"Nejat R, Torshizi MF, Najafi DJ. S protein, ACE2 and host cell proteases in SARS-CoV-2 cell entry and infectivity; is soluble ACE2 a two blade sword? a narrative review. Vaccines (Basel). 2023, 11:10.3390\/vaccines11020204","journal-title":"Vaccines (Basel)"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"Zhao MM","year":"2021","unstructured":"Zhao MM, Yang WL, Yang FY, et al.. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct Target Ther. 2021, 6:134. 10.1038\/s41392-021-00558-8","journal-title":"Signal Transduct Target Ther"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27185817","article-title":"Variation of proteolytic cleavage sites towards the N-terminal end of the s2 subunit of the novel SARS-CoV-2 Omicron sublineage BA.2.12.1","volume":"27","author":"Schilling NA","year":"2022","unstructured":"Schilling NA, Kalbacher H, Burster T. Variation of proteolytic cleavage sites towards the N-terminal end of the s2 subunit of the novel SARS-CoV-2 Omicron sublineage BA.2.12.1. Molecules. 2022, 27:10.3390\/molecules27185817","journal-title":"Molecules"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264723","article-title":"Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: the amino acid substitution N679K and P681H of the spike protein","volume":"17","author":"Mustafa Z","year":"2022","unstructured":"Mustafa Z, Kalbacher H, Burster T. Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: the amino acid substitution N679K and P681H of the spike protein. PLoS One. 2022, 17:e0264723. 10.1371\/journal.pone.0264723","journal-title":"PLoS One"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.164","article-title":"A miRNA-200c\/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition","volume":"39","author":"Zhao YF","year":"2018","unstructured":"Zhao YF, Han ML, Xiong YJ, et al.. A miRNA-200c\/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition. Acta Pharmacol Sin. 2018, 39:1034-47. 10.1038\/aps.2017.164","journal-title":"Acta Pharmacol Sin"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12010283","article-title":"Upregulation of miRNA-200c during disease progression in COVID-19 patients","volume":"12","author":"van de Sand L","year":"2022","unstructured":"van de Sand L, Bra\u00df P, Gregorius J, et al.. Upregulation of miRNA-200c during disease progression in COVID-19 patients. J Clin Med. 2022, 12:10.3390\/jcm12010283","journal-title":"J Clin Med"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.22099\/mbrc.2021.40555.1631","article-title":"MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19","volume":"10","author":"Pimenta R","year":"2021","unstructured":"Pimenta R, Viana NI, Dos Santos GA, et al.. MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19. Mol Biol Res Commun. 2021, 10:141-7. 10.22099\/mbrc.2021.40555.1631","journal-title":"Mol Biol Res Commun"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-021-00984-2","article-title":"Upregulated miR-200c is associated with downregulation of the functional receptor for severe acute respiratory syndrome coronavirus 2 ACE2 in individuals with obesity","volume":"46","author":"Bellae Papannarao J","year":"2022","unstructured":"Bellae Papannarao J, Schwenke DO, Manning P, Katare R. Upregulated miR-200c is associated with downregulation of the functional receptor for severe acute respiratory syndrome coronavirus 2 ACE2 in individuals with obesity. Int J Obes (Lond). 2022, 46:238-41. 10.1038\/s41366-021-00984-2","journal-title":"Int J Obes (Lond)"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2017.21","article-title":"miRNA-200c-3p is crucial in acute respiratory distress syndrome","volume":"3","author":"Liu Q","year":"2017","unstructured":"Liu Q, Du J, Yu X, et al.. miRNA-200c-3p is crucial in acute respiratory distress syndrome. Cell Discov. 2017, 3:17021. 10.1038\/celldisc.2017.21","journal-title":"Cell Discov"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2022.105207","article-title":"Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects","volume":"98","author":"Abdolahi S","year":"2022","unstructured":"Abdolahi S, Hosseini M, Rezaei R, et al.. Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects. Infect Genet Evol. 2022, 98:105207. 10.1016\/j.meegid.2022.105207","journal-title":"Infect Genet Evol"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010299","article-title":"MicroRNA-200c-targeted contactin 1 facilitates the replication of influenza A virus by accelerating the degradation of MAVS","volume":"18","author":"Xu S","year":"2022","unstructured":"Xu S, Han L, Wei Y, et al.. MicroRNA-200c-targeted contactin 1 facilitates the replication of influenza A virus by accelerating the degradation of MAVS. PLoS Pathog. 2022, 18:e1010299. 10.1371\/journal.ppat.1010299","journal-title":"PLoS Pathog"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03695-0","article-title":"Cell-based receptor discovery identifies host factors specifically targeted by the SARS CoV-2 spike","volume":"5","author":"Husain B","year":"2022","unstructured":"Husain B, Yuen K, Sun D, Cao S, Payandeh J, Martinez-Martin N. Cell-based receptor discovery identifies host factors specifically targeted by the SARS CoV-2 spike. Commun Biol. 2022, 5:788. 10.1038\/s42003-022-03695-0","journal-title":"Commun Biol"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans","volume":"595","author":"Sahin U","year":"2021","unstructured":"Sahin U, Muik A, Vogler I, et al.. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021, 595:572-7. 10.1038\/s41586-021-03653-6","journal-title":"Nature"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00058-22","article-title":"Stability of SARS-CoV-2-encoded proteins and their antibody levels correlate with interleukin 6 in COVID-19 patients","volume":"7","author":"Li W","year":"2022","unstructured":"Li W, Kitsios GD, Bain W, et al.. Stability of SARS-CoV-2-encoded proteins and their antibody levels correlate with interleukin 6 in COVID-19 patients. mSystems. 2022, 7:e0005822. 10.1128\/msystems.00058-22","journal-title":"mSystems"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1306441","article-title":"Influence of protein fold stability on immunogenicity and its implications for vaccine design","volume":"16","author":"Scheiblhofer S","year":"2017","unstructured":"Scheiblhofer S, Laimer J, Machado Y, Weiss R, Thalhamer J. Influence of protein fold stability on immunogenicity and its implications for vaccine design. Expert Rev Vaccines. 2017, 16:479-89. 10.1080\/14760584.2017.1306441","journal-title":"Expert Rev Vaccines"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)00053-4","article-title":"Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha\/beta gene induction","volume":"13","author":"Sato M","year":"2000","unstructured":"Sato M, Suemori H, Hata N, et al.. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha\/beta gene induction. Immunity. 2000, 13:539-48. 10.1016\/s1074-7613(00)00053-4","journal-title":"Immunity"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1236923","article-title":"IRF7: role and regulation in immunity and autoimmunity","volume":"14","author":"Ma W","year":"2023","unstructured":"Ma W, Huang G, Wang Z, Wang L, Gao Q. IRF7: role and regulation in immunity and autoimmunity. Front Immunol. 2023, 14:1236923. 10.3389\/fimmu.2023.1236923","journal-title":"Front Immunol"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190841","article-title":"Interferon regulatory factor 7 in inflammation, cancer and infection","volume":"14","author":"Qing F","year":"2023","unstructured":"Qing F, Liu Z. Interferon regulatory factor 7 in inflammation, cancer and infection. Front Immunol. 2023, 14:1190841. 10.3389\/fimmu.2023.1190841","journal-title":"Front Immunol"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656700","article-title":"SARS-CoV-2 Spike targets USP33-IRF9 axis via exosomal miR-148a to activate human microglia","volume":"12","author":"Mishra R","year":"2021","unstructured":"Mishra R, Banerjea AC. SARS-CoV-2 Spike targets USP33-IRF9 axis via exosomal miR-148a to activate human microglia. Front Immunol. 2021, 12:656700. 10.3389\/fimmu.2021.656700","journal-title":"Front Immunol"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien J","year":"2018","unstructured":"O'Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018, 9:402. 10.3389\/fendo.2018.00402","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201490345","article-title":"Burning down the house: IRF7 makes the difference for microglia","volume":"33","author":"Hagemeyer N","year":"2014","unstructured":"Hagemeyer N, Prinz M. Burning down the house: IRF7 makes the difference for microglia. EMBO J. 2014, 33:2885-6. 10.15252\/embj.201490345","journal-title":"EMBO J"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.3390\/v2010298","article-title":"Dual role of p53 in innate antiviral immunity","volume":"2","author":"Rivas C","year":"2010","unstructured":"Rivas C, Aaronson SA, Munoz-Fontela C. Dual role of p53 in innate antiviral immunity. Viruses. 2010, 2:298-313. 10.3390\/v2010298","journal-title":"Viruses"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00923","article-title":"Strategies to target ISG15 and USP18 toward therapeutic applications","volume":"7","author":"Jim\u00e9nez Fern\u00e1ndez D","year":"2019","unstructured":"Jim\u00e9nez Fern\u00e1ndez D, Hess S, Knobeloch KP. Strategies to target ISG15 and USP18 toward therapeutic applications. Front Chem. 2019, 7:923. 10.3389\/fchem.2019.00923","journal-title":"Front Chem"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10970-y","article-title":"A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription","volume":"10","author":"Platanitis E","year":"2019","unstructured":"Platanitis E, Demiroz D, Schneller A, et al.. A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription. Nat Commun. 2019, 10:2921. 10.1038\/s41467-019-10970-y","journal-title":"Nat Commun"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow YJ","year":"2022","unstructured":"Crow YJ, Stetson DB. The type I interferonopathies: 10 years on. Nat Rev Immunol. 2022, 22:471-83. 10.1038\/s41577-021-00633-9","journal-title":"Nat Rev Immunol"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01831","article-title":"Interferon regulatory factor 9 structure and regulation","volume":"9","author":"Paul A","year":"2018","unstructured":"Paul A, Tang TH, Ng SK. Interferon regulatory factor 9 structure and regulation. Front Immunol. 2018, 9:1831. 10.3389\/fimmu.2018.01831","journal-title":"Front Immunol"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphys.2020.07.001","article-title":"P53 deficiency potentiates LPS-Induced acute lung injury in vivo","volume":"3","author":"Uddin MA","year":"2020","unstructured":"Uddin MA, Akhter MS, Kubra KT, Barabutis N. P53 deficiency potentiates LPS-Induced acute lung injury in vivo. Curr Res Physiol. 2020, 3:30-3. 10.1016\/j.crphys.2020.07.001","journal-title":"Curr Res Physiol"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100814","article-title":"S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study","volume":"13","author":"Singh N","year":"2020","unstructured":"Singh N, Bharara Singh A. S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study. Transl Oncol. 2020, 13:100814. 10.1016\/j.tranon.2020.100814","journal-title":"Transl Oncol"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2021.05.004","article-title":"Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients","volume":"236","author":"de Gonzalo-Calvo D","year":"2021","unstructured":"de Gonzalo-Calvo D, Ben\u00edtez ID, Pinilla L, et al.. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl Res. 2021, 236:147-59. 10.1016\/j.trsl.2021.05.004","journal-title":"Transl Res"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.7150\/thno.78164","article-title":"Circulating microRNAs as emerging regulators of COVID-19","volume":"13","author":"Liang Y","year":"2023","unstructured":"Liang Y, Fang D, Gao X, et al.. Circulating microRNAs as emerging regulators of COVID-19. Theranostics. 2023, 13:125-47. 10.7150\/thno.78164","journal-title":"Theranostics"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S238317","article-title":"miR-148a affects polarization of THP-1-derived macrophages and reduces recruitment of tumor-associated macrophages via targeting SIRP\u03b1","volume":"12","author":"Ma D","year":"2020","unstructured":"Ma D, Zhang Y, Chen G, Yan J. miR-148a affects polarization of THP-1-derived macrophages and reduces recruitment of tumor-associated macrophages via targeting SIRP\u03b1. Cancer Manag Res. 2020, 12:8067-77. 10.2147\/CMAR.S238317","journal-title":"Cancer Manag Res"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01327","article-title":"miR-148a-3p mediates notch signaling to promote the differentiation and M1 activation of macrophages","volume":"8","author":"Huang F","year":"2017","unstructured":"Huang F, Zhao JL, Wang L, et al.. miR-148a-3p mediates notch signaling to promote the differentiation and M1 activation of macrophages. Front Immunol. 2017, 8:1327. 10.3389\/fimmu.2017.01327","journal-title":"Front Immunol"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.928704","article-title":"NOTCH signaling in COVID-19: a central hub controlling genes, proteins, and cells that mediate SARS-CoV-2 entry, the inflammatory response, and lung regeneration","volume":"12","author":"Baindara P","year":"2022","unstructured":"Baindara P, Sarker MB, Earhart AP, Mandal SM, Schrum AG. NOTCH signaling in COVID-19: a central hub controlling genes, proteins, and cells that mediate SARS-CoV-2 entry, the inflammatory response, and lung regeneration. Front Cell Infect Microbiol. 2022, 12:928704. 10.3389\/fcimb.2022.928704","journal-title":"Front Cell Infect Microbiol"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00754-8","article-title":"\u03b3-Secretase in Alzheimer's disease","volume":"54","author":"Hur JY","year":"2022","unstructured":"Hur JY. \u03b3-Secretase in Alzheimer's disease. Exp Mol Med. 2022, 54:433-46. 10.1038\/s12276-022-00754-8","journal-title":"Exp Mol Med"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073532","article-title":"Modulation of notch signaling pathway by bioactive dietary agents","volume":"23","author":"Kiesel VA","year":"2022","unstructured":"Kiesel VA, Stan SD. Modulation of notch signaling pathway by bioactive dietary agents. Int J Mol Sci. 2022, 23:10.3390\/ijms23073532","journal-title":"Int J Mol Sci"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020348","article-title":"Conserved MicroRNAs in human nasopharynx tissue samples from swabs are differentially expressed in response to SARS-CoV-2","volume":"13","author":"Eichmeier A","year":"2022","unstructured":"Eichmeier A, Kiss T, Kocanova M, Hakalova E, Spetik M, Cechova J, Tichy B. Conserved MicroRNAs in human nasopharynx tissue samples from swabs are differentially expressed in response to SARS-CoV-2. Genes (Basel). 2022, 13:10.3390\/genes13020348","journal-title":"Genes (Basel)"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2032057","article-title":"The effects of secretory IgA in the mucosal immune system","volume":"2020","author":"Li Y","year":"2020","unstructured":"Li Y, Jin L, Chen T. The effects of secretory IgA in the mucosal immune system. Biomed Res Int. 2020, 2020:2032057. 10.1155\/2020\/2032057","journal-title":"Biomed Res Int"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10280","article-title":"miR\u2011148a modulates the viability, migration and invasion of oral squamous cell carcinoma cells by regulating HLA\u2011G expression","volume":"20","author":"Zhang Y","year":"2019","unstructured":"Zhang Y, Jin X, Wang J. miR\u2011148a modulates the viability, migration and invasion of oral squamous cell carcinoma cells by regulating HLA\u2011G expression. Mol Med Rep. 2019, 20:795-801. 10.3892\/mmr.2019.10280","journal-title":"Mol Med Rep"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01613","article-title":"HLA-G expressing immune cells in immune mediated diseases","volume":"11","author":"Contini P","year":"2020","unstructured":"Contini P, Murdaca G, Puppo F, Negrini S. HLA-G expressing immune cells in immune mediated diseases. Front Immunol. 2020, 11:1613. 10.3389\/fimmu.2020.01613","journal-title":"Front Immunol"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04592-9","article-title":"Induction of pulmonary HLA-G expression by SARS-CoV-2 infection","volume":"79","author":"Seliger B","year":"2022","unstructured":"Seliger B, Jasinski-Bergner S, Massa C, et al.. Induction of pulmonary HLA-G expression by SARS-CoV-2 infection. Cell Mol Life Sci. 2022, 79:582. 10.1007\/s00018-022-04592-9","journal-title":"Cell Mol Life Sci"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-010-0580-7","article-title":"Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association","volume":"68","author":"Donadi EA","year":"2011","unstructured":"Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci. 2011, 68:369-95. 10.1007\/s00018-010-0580-7","journal-title":"Cell Mol Life Sci"},{"key":"ref186","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.830","article-title":"Interleukin 10 induces the expression of membrane-bound HLA- G and the production of soluble HLA-G on HeLa CCL-2 cells","volume":"7","author":"Hasanah N","year":"2019","unstructured":"Hasanah N, Mintaroem K, Fitri LE, Noorhamdani N. Interleukin 10 induces the expression of membrane-bound HLA- G and the production of soluble HLA-G on HeLa CCL-2 cells. Open Access Maced J Med Sci. 2019, 7:3554-8. 10.3889\/oamjms.2019.830","journal-title":"Open Access Maced J Med Sci"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01178","article-title":"HLA-G genotype\/expression\/disease association studies: success, hurdles, and perspectives","volume":"11","author":"Amodio G","year":"2020","unstructured":"Amodio G, Gregori S. HLA-G genotype\/expression\/disease association studies: success, hurdles, and perspectives. Front Immunol. 2020, 11:1178. 10.3389\/fimmu.2020.01178","journal-title":"Front Immunol"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.728896","article-title":"SARS-CoV-2 coronavirus Spike protein-induced apoptosis, inflammatory, and oxidative stress responses in THP-1-like-macrophages: potential role of angiotensin-converting enzyme inhibitor (perindopril)","volume":"12","author":"Barhoumi T","year":"2021","unstructured":"Barhoumi T, Alghanem B, Shaibah H, et al.. SARS-CoV-2 coronavirus Spike protein-induced apoptosis, inflammatory, and oxidative stress responses in THP-1-like-macrophages: potential role of angiotensin-converting enzyme inhibitor (perindopril). Front Immunol. 2021, 12:728896. 10.3389\/fimmu.2021.728896","journal-title":"Front Immunol"},{"key":"ref189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.733921","article-title":"Metformin suppresses monocyte immunometabolic activation by SARS-CoV-2 Spike protein subunit 1","volume":"12","author":"Cory TJ","year":"2021","unstructured":"Cory TJ, Emmons RS, Yarbro JR, Davis KL, Pence BD. Metformin suppresses monocyte immunometabolic activation by SARS-CoV-2 Spike protein subunit 1. Front Immunol. 2021, 12:733921. 10.3389\/fimmu.2021.733921","journal-title":"Front Immunol"},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva M","year":"2020","unstructured":"Saraiva M, Vieira P, O'Garra A. Biology and therapeutic potential of interleukin-10. J Exp Med. 2020, 217:10.1084\/jem.20190418","journal-title":"J Exp Med"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.84790","article-title":"SARS-CoV-2 uses CD4 to infect T helper lymphocytes","volume":"12","author":"Brunetti NS","year":"2023","unstructured":"Brunetti NS, Davanzo GG, de Moraes D, et al.. SARS-CoV-2 uses CD4 to infect T helper lymphocytes. Elife. 2023, 12:10.7554\/eLife.84790","journal-title":"Elife"},{"key":"ref192","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444637","article-title":"miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2","volume":"45","author":"Porstner M","year":"2015","unstructured":"Porstner M, Winkelmann R, Daum P, et al.. miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2. Eur J Immunol. 2015, 45:1206-15. 10.1002\/eji.201444637","journal-title":"Eur J Immunol"},{"key":"ref193","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048993","article-title":"miR-148a controls metabolic programming and survival of mature CD19-negative plasma cells in mice","volume":"51","author":"Pracht K","year":"2021","unstructured":"Pracht K, Meinzinger J, Schulz SR, et al.. miR-148a controls metabolic programming and survival of mature CD19-negative plasma cells in mice. Eur J Immunol. 2021, 51:1089-109. 10.1002\/eji.202048993","journal-title":"Eur J Immunol"},{"key":"ref194","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444633","article-title":"miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim","volume":"45","author":"Haftmann C","year":"2015","unstructured":"Haftmann C, Stittrich AB, Zimmermann J, et al.. miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim. Eur J Immunol. 2015, 45:1192-205. 10.1002\/eji.201444633","journal-title":"Eur J Immunol"},{"key":"ref195","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01261-5","article-title":"MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1","volume":"8","author":"Pan B","year":"2022","unstructured":"Pan B, Zheng L, Liu S, et al.. MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1. Cell Death Discov. 2022, 8:470. 10.1038\/s41420-022-01261-5","journal-title":"Cell Death Discov"},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-019-0344-x","article-title":"MicroRNA-148a\/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cells","volume":"51","author":"Kim H","year":"2019","unstructured":"Kim H, Ko Y, Park H, et al.. MicroRNA-148a\/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cells. Exp Mol Med. 2019, 51:1-11. 10.1038\/s12276-019-0344-x","journal-title":"Exp Mol Med"},{"key":"ref197","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd3072","article-title":"Neuropilin-1 is a host factor for SARS-CoV-2 infection","volume":"370","author":"Daly JL","year":"2020","unstructured":"Daly JL, Simonetti B, Klein K, et al.. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020, 370:861-5. 10.1126\/science.abd3072","journal-title":"Science"},{"key":"ref198","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.03.074","article-title":"Virus-receptor interactions of SARS-CoV-2 spikereceptor-binding domain and human neuropilin-1 b1 domain","volume":"28","author":"Alnomasy SF","year":"2021","unstructured":"Alnomasy SF. Virus-receptor interactions of SARS-CoV-2 spikereceptor-binding domain and human neuropilin-1 b1 domain. Saudi J Biol Sci. 2021, 28:3926-8. 10.1016\/j.sjbs.2021.03.074","journal-title":"Saudi J Biol Sci"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132772","article-title":"The role of neuropilin-1 (NRP-1) in SARS-CoV-2 infection: review","volume":"10","author":"Gudowska-Sawczuk M","year":"2021","unstructured":"Gudowska-Sawczuk M, Mroczko B. The role of neuropilin-1 (NRP-1) in SARS-CoV-2 infection: review. J Clin Med. 2021, 10:10.3390\/jcm10132772","journal-title":"J Clin Med"},{"key":"ref200","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01228","article-title":"Multifaceted role of neuropilins in the immune system: potential targets for immunotherapy","volume":"8","author":"Roy S","year":"2017","unstructured":"Roy S, Bag AK, Singh RK, Talmadge JE, Batra SK, Datta K. Multifaceted role of neuropilins in the immune system: potential targets for immunotherapy. Front Immunol. 2017, 8:1228. 10.3389\/fimmu.2017.01228","journal-title":"Front Immunol"},{"key":"ref201","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02209","article-title":"Neuropilin-1 Acts as a Receptor for Complement Split Products","author":"Claire Battin","year":"2019","unstructured":"Claire Battin, Annika De Sousa Linhares, Wolfgang Paster, David E. Isenman, Markus Wahrmann, Judith Leitner, Gerhard J. Neuropilin-1 Acts as a Receptor for Complement Split Products. Front. Immunol. 2019, 10.3389\/fimmu.2019.02209","journal-title":"Front. Immunol"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147358","article-title":"Specific neuropilins expression in alveolar macrophages among tissue-specific macrophages","volume":"11","author":"Aung NY","year":"2016","unstructured":"Aung NY, Ohe R, Meng H, Kabasawa T, Yang S, Kato T, Yamakawa M. Specific neuropilins expression in alveolar macrophages among tissue-specific macrophages. PLoS One. 2016, 11:e0147358. 10.1371\/journal.pone.0147358","journal-title":"PLoS One"},{"key":"ref203","doi-asserted-by":"publisher","DOI":"10.1016\/bs.ircmb.2022.01.001","article-title":"Pulmonary macrophages and SARS-Cov2 infection","volume":"367","author":"Bain CC","year":"2022","unstructured":"Bain CC, Lucas CD, Rossi AG. Pulmonary macrophages and SARS-Cov2 infection. Int Rev Cell Mol Biol. 2022, 367:1-28. 10.1016\/bs.ircmb.2022.01.001","journal-title":"Int Rev Cell Mol Biol"},{"key":"ref204","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03148-w","article-title":"Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia","volume":"590","author":"Grant RA","year":"2021","unstructured":"Grant RA, Morales-Nebreda L, Markov NS, et al.. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature. 2021, 590:635-41. 10.1038\/s41586-020-03148-w","journal-title":"Nature"},{"key":"ref205","doi-asserted-by":"publisher","DOI":"10.3390\/idr14020029","article-title":"Conservation and enhanced binding of SARS-CoV-2 Omicron Spike protein to coreceptor neuropilin-1 predicted by docking analysis","volume":"14","author":"Baindara P","year":"2022","unstructured":"Baindara P, Roy D, Mandal SM, Schrum AG. Conservation and enhanced binding of SARS-CoV-2 Omicron Spike protein to coreceptor neuropilin-1 predicted by docking analysis. Infect Dis Rep. 2022, 14:243-9. 10.3390\/idr14020029","journal-title":"Infect Dis Rep"},{"key":"ref206","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00731-9","article-title":"Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor","volume":"52","author":"Onabajo OO","year":"2020","unstructured":"Onabajo OO, Banday AR, Stanifer ML, et al.. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat Genet. 2020, 52:1283-93. 10.1038\/s41588-020-00731-9","journal-title":"Nat Genet"},{"key":"ref207","doi-asserted-by":"publisher","DOI":"10.3390\/children9081210","article-title":"From fetal to neonatal neuroimaging in TORCH infections: a pictorial review","volume":"9","author":"Lucignani G","year":"2022","unstructured":"Lucignani G, Guarnera A, Rossi-Espagnet MC, et al.. From fetal to neonatal neuroimaging in TORCH infections: a pictorial review. Children (Basel). 2022, 9:10.3390\/children9081210","journal-title":"Children (Basel)"},{"key":"ref208","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.07.017","article-title":"Interferons and proinflammatory cytokines in pregnancy and fetal development","volume":"49","author":"Yockey LJ","year":"2018","unstructured":"Yockey LJ, Iwasaki A. Interferons and proinflammatory cytokines in pregnancy and fetal development. Immunity. 2018, 49:397-412. 10.1016\/j.immuni.2018.07.017","journal-title":"Immunity"},{"key":"ref209","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.871583","article-title":"p53\/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)","volume":"13","author":"Milani D","year":"2022","unstructured":"Milani D, Caruso L, Zauli E, et al.. p53\/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics). Front Pharmacol. 2022, 13:871583. 10.3389\/fphar.2022.871583","journal-title":"Front Pharmacol"},{"key":"ref210","doi-asserted-by":"publisher","DOI":"10.1593\/neo.121534","article-title":"p53-independent roles of MDM2 in NF-\u03baB signaling: implications for cancer therapy, wound healing, and autoimmune diseases","volume":"14","author":"Thomasova D","year":"2012","unstructured":"Thomasova D, Mulay SR, Bruns H, Anders HJ. p53-independent roles of MDM2 in NF-\u03baB signaling: implications for cancer therapy, wound healing, and autoimmune diseases. Neoplasia. 2012, 14:1097-101. 10.1593\/neo.121534","journal-title":"Neoplasia"},{"key":"ref211","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115881","article-title":"Potential of the miR-200 family as a target for developing anti-cancer therapeutics","volume":"23","author":"Jo H","year":"2022","unstructured":"Jo H, Shim K, Jeoung D. Potential of the miR-200 family as a target for developing anti-cancer therapeutics. Int J Mol Sci. 2022, 23:10.3390\/ijms23115881","journal-title":"Int J Mol Sci"},{"key":"ref212","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.08.012","article-title":"Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes","volume":"139","author":"Riani M","year":"2017","unstructured":"Riani M, Le Jan S, Pl\u00e9e J, et al.. Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes. J Allergy Clin Immunol. 2017, 139:863-872.e3. 10.1016\/j.jaci.2016.08.012","journal-title":"J Allergy Clin Immunol"},{"key":"ref213","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0508OC","article-title":"CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin","volume":"187","author":"Ichikawa A","year":"2013","unstructured":"Ichikawa A, Kuba K, Morita M, et al.. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med. 2013, 187:65-77. 10.1164\/rccm.201203-0508OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref214","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.3.1548","article-title":"CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma","volume":"165","author":"Jinquan T","year":"2000","unstructured":"Jinquan T, Jing C, Jacobi HH, et al.. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. J Immunol. 2000, 165:1548-56. 10.4049\/jimmunol.165.3.1548","journal-title":"J Immunol"},{"key":"ref215","doi-asserted-by":"publisher","DOI":"10.1159\/000357780","article-title":"The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis","volume":"21","author":"Vazirinejad R","year":"2014","unstructured":"Vazirinejad R, Ahmadi Z, Kazemi Arababadi M, Hassanshahi G, Kennedy D. The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis. Neuroimmunomodulation. 2014, 21:322-30. 10.1159\/000357780","journal-title":"Neuroimmunomodulation"},{"key":"ref216","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.882017","article-title":"Evolution, Expression and Functional Analysis of CXCR3 in Neuronal and Cardiovascular Diseases: A Narrative Review","volume":"10","author":"Satarkar D","year":"2022","unstructured":"Satarkar D, Patra C. Evolution, Expression and Functional Analysis of CXCR3 in Neuronal and Cardiovascular Diseases: A Narrative Review. Front Cell Dev Biol. 2022, 10:882017. 10.3389\/fcell.2022.882017","journal-title":"Front Cell Dev Biol"},{"key":"ref217","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1128154","article-title":"The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets","volume":"10","author":"Maglie R","year":"2023","unstructured":"Maglie R, Solimani F, Didona D, Pipit\u00f2 C, Antiga E, Di Zenzo G. The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets. Front Med (Lausanne). 2023, 10:1128154. 10.3389\/fmed.2023.1128154","journal-title":"Front Med (Lausanne)"},{"key":"ref218","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20199007","article-title":"Bullous pemphigoid","volume":"94","author":"Miyamoto D","year":"2019","unstructured":"Miyamoto D, Santi CG, Aoki V, Maruta CW. Bullous pemphigoid. An Bras Dermatol. 2019, 94:133-46. 10.1590\/abd1806-4841.20199007","journal-title":"An Bras Dermatol"},{"key":"ref219","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.912876","article-title":"Insights into the pathogenesis of bullous pemphigoid: the role of complement-independent mechanisms","volume":"13","author":"Cole C","year":"2022","unstructured":"Cole C, Vinay K, Borradori L, Amber KT. Insights into the pathogenesis of bullous pemphigoid: the role of complement-independent mechanisms. Front Immunol. 2022, 13:912876. 10.3389\/fimmu.2022.912876","journal-title":"Front Immunol"},{"key":"ref220","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16086","article-title":"Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one center","volume":"61","author":"Afacan E","year":"2022","unstructured":"Afacan E, Edek YC, \u0130lter N, G\u00fclekon A. Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one center. Int J Dermatol. 2022, 61:626-7. 10.1111\/ijd.16086","journal-title":"Int J Dermatol"},{"key":"ref221","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.103420","article-title":"Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report","volume":"75","author":"Alshammari F","year":"2022","unstructured":"Alshammari F, Abuzied Y, Korairi A, Alajlan M, Alzomia M, AlSheef M. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report. Ann Med Surg (Lond). 2022, 75:103420. 10.1016\/j.amsu.2022.103420","journal-title":"Ann Med Surg (Lond)"},{"key":"ref222","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.841506","article-title":"Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study","volume":"9","author":"Maronese CA","year":"2022","unstructured":"Maronese CA, Caproni M, Moltrasio C, et al.. Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study. Front Med (Lausanne). 2022, 9:841506. 10.3389\/fmed.2022.841506","journal-title":"Front Med (Lausanne)"},{"key":"ref223","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.152072","article-title":"CD147-spike protein interaction in COVID-19: get the ball rolling with a novel receptor and therapeutic target","volume":"808","author":"Behl T","year":"2022","unstructured":"Behl T, Kaur I, Aleya L, et al.. CD147-spike protein interaction in COVID-19: get the ball rolling with a novel receptor and therapeutic target. Sci Total Environ. 2022, 808:152072. 10.1016\/j.scitotenv.2021.152072","journal-title":"Sci Total Environ"},{"key":"ref224","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvv127","article-title":"Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners","volume":"159","author":"Muramatsu T","year":"2016","unstructured":"Muramatsu T. Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners. J Biochem. 2016, 159:481-90. 10.1093\/jb\/mvv127","journal-title":"J Biochem"},{"key":"ref225","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070011","article-title":"Galectin-3 induces clustering of CD147 and integrin-\u03b21 transmembrane glycoprotein receptors on the RPE cell surface","volume":"8","author":"Priglinger CS","year":"2013","unstructured":"Priglinger CS, Szober CM, Priglinger SG, et al.. Galectin-3 induces clustering of CD147 and integrin-\u03b21 transmembrane glycoprotein receptors on the RPE cell surface. PLoS One. 2013, 8:e70011. 10.1371\/journal.pone.0070011","journal-title":"PLoS One"},{"key":"ref226","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.148510","article-title":"Molecular basis for MMP9 induction and disruption of epithelial cell-cell contacts by galectin-3","volume":"127","author":"Mauris J","year":"2014","unstructured":"Mauris J, Woodward AM, Cao Z, Panjwani N, Arg\u00fceso P. Molecular basis for MMP9 induction and disruption of epithelial cell-cell contacts by galectin-3. J Cell Sci. 2014, 127:3141-8. 10.1242\/jcs.148510","journal-title":"J Cell Sci"},{"key":"ref227","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150256","article-title":"How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity","volume":"36","author":"Grass GD","year":"2015","unstructured":"Grass GD, Toole BP. How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity. Biosci Rep. 2015, 36:e00283. 10.1042\/BSR20150256","journal-title":"Biosci Rep"},{"key":"ref228","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831763","article-title":"The S1 Subunit of the SARS-CoV-2 Spike protein activates human monocytes to produce cytokines linked to COVID-19: relevance to galectin-3","volume":"13","author":"Schroeder JT","year":"2022","unstructured":"Schroeder JT, Bieneman AP. The S1 Subunit of the SARS-CoV-2 Spike protein activates human monocytes to produce cytokines linked to COVID-19: relevance to galectin-3. Front Immunol. 2022, 13:831763. 10.3389\/fimmu.2022.831763","journal-title":"Front Immunol"},{"key":"ref229","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang K","year":"2020","unstructured":"Wang K, Chen W, Zhang Z, et al.. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020, 5:283. 10.1038\/s41392-020-00426-x","journal-title":"Signal Transduct Target Ther"},{"key":"ref230","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80464-1","article-title":"No evidence for basigin\/CD147 as a direct SARS-CoV-2 spike binding receptor","volume":"11","author":"Shilts J","year":"2021","unstructured":"Shilts J, Crozier TW, Greenwood EJ, Lehner PJ, Wright GJ. No evidence for basigin\/CD147 as a direct SARS-CoV-2 spike binding receptor. Sci Rep. 2021, 11:413. 10.1038\/s41598-020-80464-1","journal-title":"Sci Rep"},{"key":"ref231","doi-asserted-by":"publisher","DOI":"10.1086\/427811","article-title":"Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus","volume":"191","author":"Chen Z","year":"2005","unstructured":"Chen Z, Mi L, Xu J, et al.. Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis. 2005, 191:755-60. 10.1086\/427811","journal-title":"J Infect Dis"},{"key":"ref232","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab189","article-title":"in silico evaluation of cyclophilin inhibitors as potential treatment for SARS-CoV-2","volume":"8","author":"Laurie K","year":"2021","unstructured":"Laurie K, Holcomb D, Kames J, Komar AA, DiCuccio M, Ibla JC, Kimchi-Sarfaty C. in silico evaluation of cyclophilin inhibitors as potential treatment for SARS-CoV-2. Open Forum Infect Dis. 2021, 8:ofab189. 10.1093\/ofid\/ofab189","journal-title":"Open Forum Infect Dis"},{"key":"ref233","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09440620","article-title":"Expression of CD147 and cyclophilin A in kidneys of patients with COVID-19","volume":"16","author":"Su H","year":"2021","unstructured":"Su H, Wan C, Wang ZD, et al.. Expression of CD147 and cyclophilin A in kidneys of patients with COVID-19. Clin J Am Soc Nephrol. 2021, 16:618-9. 10.2215\/CJN.09440620","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref234","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2020.100056","article-title":"Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19","volume":"7","author":"Liu C","year":"2020","unstructured":"Liu C, von Brunn A, Zhu D. Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19. Med Drug Discov. 2020, 7:100056. 10.1016\/j.medidd.2020.100056","journal-title":"Med Drug Discov"},{"key":"ref235","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.75337","article-title":"MMP-9\/BDNF ratio predicts more severe COVID-19 outcomes","volume":"19","author":"Savic G","year":"2022","unstructured":"Savic G, Stevanovic I, Mihajlovic D, Jurisevic M, Gajovic N, Jovanovic I, Ninkovic M. MMP-9\/BDNF ratio predicts more severe COVID-19 outcomes. Int J Med Sci. 2022, 19:1903-11. 10.7150\/ijms.75337","journal-title":"Int J Med Sci"},{"key":"ref236","doi-asserted-by":"publisher","DOI":"10.3390\/biom12050692","article-title":"Matrix metalloproteinases in health and disease in the times of COVID-19","volume":"12","author":"Fernandez-Patron C","year":"2022","unstructured":"Fernandez-Patron C, Hardy E. Matrix metalloproteinases in health and disease in the times of COVID-19. Biomolecules. 2022, 12:10.3390\/biom12050692","journal-title":"Biomolecules"},{"key":"ref237","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00519-22","article-title":"Metalloproteinase-dependent and TMPRSS2-independent cell surface entry pathway of SARS-CoV-2 requires the furin cleavage site and the S2 domain of spike protein","volume":"13","author":"Yamamoto M","year":"2022","unstructured":"Yamamoto M, Gohda J, Kobayashi A, et al.. Metalloproteinase-dependent and TMPRSS2-independent cell surface entry pathway of SARS-CoV-2 requires the furin cleavage site and the S2 domain of spike protein. mBio. 2022, 13:e0051922. 10.1128\/mbio.00519-22","journal-title":"mBio"},{"key":"ref238","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.02.006","article-title":"Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration","volume":"178","author":"Pons M","year":"2011","unstructured":"Pons M, Cousins SW, Alcazar O, Striker GE, Marin-Casta\u00f1o ME. Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration. Am J Pathol. 2011, 178:2665-81. 10.1016\/j.ajpath.2011.02.006","journal-title":"Am J Pathol"},{"key":"ref239","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras FP","year":"2020","unstructured":"Veras FP, Pontelli MC, Silva CM, et al.. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020, 217:10.1084\/jem.20201129","journal-title":"J Exp Med"},{"key":"ref240","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-021-01442-x","article-title":"Neutrophil-induced liver injury and interactions between neutrophils and liver sinusoidal endothelial cells","volume":"44","author":"Wang Y","year":"2021","unstructured":"Wang Y, Liu Y. Neutrophil-induced liver injury and interactions between neutrophils and liver sinusoidal endothelial cells. Inflammation. 2021, 44:1246-62. 10.1007\/s10753-021-01442-x","journal-title":"Inflammation"},{"key":"ref241","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.708302","article-title":"NETosis and the immune system in COVID-19: mechanisms and potential treatments","volume":"12","author":"Gillot C","year":"2021","unstructured":"Gillot C, Favresse J, Mullier F, Lecompte T, Dogn\u00e9 JM, Douxfils J. NETosis and the immune system in COVID-19: mechanisms and potential treatments. Front Pharmacol. 2021, 12:708302. 10.3389\/fphar.2021.708302","journal-title":"Front Pharmacol"},{"key":"ref242","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.11.021","article-title":"Neutrophil extracellular traps induce human\u00a0Th17 cells: effect of psoriasis-associated TRAF3IP2 genotype","volume":"139","author":"Lambert S","year":"2019","unstructured":"Lambert S, Hambro CA, Johnston A, Stuart PE, Tsoi LC, Nair RP, Elder JT. Neutrophil extracellular traps induce human\u00a0Th17 cells: effect of psoriasis-associated TRAF3IP2 genotype. J Invest Dermatol. 2019, 139:1245-53. 10.1016\/j.jid.2018.11.021","journal-title":"J Invest Dermatol"},{"key":"ref243","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-8-3-3","article-title":"The amyloidoses: clinical features, diagnosis and treatment","volume":"8","author":"Baker KR","year":"2012","unstructured":"Baker KR, Rice L. The amyloidoses: clinical features, diagnosis and treatment. Methodist Debakey Cardiovasc J. 2012, 8:3-7. 10.14797\/mdcj-8-3-3","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref244","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071139","article-title":"COVID-19 infection and vaccination and its relation to amyloidosis: what do we know currently?","volume":"11","author":"Leung WY","year":"2023","unstructured":"Leung WY, Wu HH, Floyd L, Ponnusamy A, Chinnadurai R. COVID-19 infection and vaccination and its relation to amyloidosis: what do we know currently?. Vaccines (Basel). 2023, 11:10.3390\/vaccines11071139","journal-title":"Vaccines (Basel)"},{"key":"ref245","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20220154","article-title":"The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME\/CFS: evidence, mechanisms, and therapeutic implications","volume":"479","author":"Kell DB","year":"2022","unstructured":"Kell DB, Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME\/CFS: evidence, mechanisms, and therapeutic implications. Biochem J. 2022, 479:1653-708. 10.1042\/BCJ20220154","journal-title":"Biochem J"},{"key":"ref246","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-5343","article-title":"Analysis of the autoimmune response against BP180 in patients with Alzheimer's disease","volume":"9","author":"Wang YN","year":"2021","unstructured":"Wang YN, Hammers CM, Mao X, Jin HZ, Yuan J, Li L. Analysis of the autoimmune response against BP180 in patients with Alzheimer's disease. Ann Transl Med. 2021, 9:107. 10.21037\/atm-20-5343","journal-title":"Ann Transl Med"},{"key":"ref247","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101212","article-title":"Proteolytic cleavage of the SARS-CoV-2 Spike protein and the role of the novel S1\/S2 site","volume":"23","author":"Jaimes JA","year":"2020","unstructured":"Jaimes JA, Millet JK, Whittaker GR. Proteolytic cleavage of the SARS-CoV-2 Spike protein and the role of the novel S1\/S2 site. iScience. 2020, 23:101212. 10.1016\/j.isci.2020.101212","journal-title":"iScience"},{"key":"ref248","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00919-x","article-title":"ACE2-independent infection of T lymphocytes by SARS-CoV-2","volume":"7","author":"Shen XR","year":"2022","unstructured":"Shen XR, Geng R, Li Q, et al.. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022, 7:83. 10.1038\/s41392-022-00919-x","journal-title":"Signal Transduct Target Ther"},{"key":"ref249","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.842949","article-title":"Myeloid-derived suppressor cells in COVID-19: the paradox of good","volume":"13","author":"Grassi G","year":"2022","unstructured":"Grassi G, Notari S, Gili S, et al.. Myeloid-derived suppressor cells in COVID-19: the paradox of good. Front Immunol. 2022, 13:842949. 10.3389\/fimmu.2022.842949","journal-title":"Front Immunol"},{"key":"ref250","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.10.008","article-title":"Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy","volume":"189","author":"Kamran N","year":"2018","unstructured":"Kamran N, Chandran M, Lowenstein PR, Castro MG. Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy. Clin Immunol. 2018, 189:34-42. 10.1016\/j.clim.2016.10.008","journal-title":"Clin Immunol"},{"key":"ref251","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01223","article-title":"IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients","volume":"9","author":"Tobin RP","year":"2019","unstructured":"Tobin RP, Jordan KR, Kapoor P, et al.. IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients. Front Oncol. 2019, 9:1223. 10.3389\/fonc.2019.01223","journal-title":"Front Oncol"},{"key":"ref252","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105479","article-title":"Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice","volume":"25","author":"Gao FX","year":"2022","unstructured":"Gao FX, Wu RX, Shen MY, et al.. Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice. iScience. 2022, 25:105479. 10.1016\/j.isci.2022.105479","journal-title":"iScience"},{"key":"ref253","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009850","article-title":"Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease","volume":"17","author":"Pe\u00f1aloza HF","year":"2021","unstructured":"Pe\u00f1aloza HF, Lee JS, Ray P. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease. PLoS Pathog. 2021, 17:e1009850. 10.1371\/journal.ppat.1009850","journal-title":"PLoS Pathog"},{"key":"ref254","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang P","year":"2023","unstructured":"Irrgang P, Gerling J, Kocher K, et al.. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Sci Immunol. 2023, 8:eade2798. 10.1126\/sciimmunol.ade2798","journal-title":"Sci Immunol"},{"key":"ref255","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"van de Veen W","year":"2013","unstructured":"van de Veen W, Stanic B, Yaman G, et al.. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol. 2013, 131:1204-12. 10.1016\/j.jaci.2013.01.014","journal-title":"J Allergy Clin Immunol"},{"key":"ref256","doi-asserted-by":"publisher","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten M","year":"2007","unstructured":"van der Neut Kolfschoten M, Schuurman J, Losen M, et al.. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science. 2007, 317:1554-7. 10.1126\/science.1144603","journal-title":"Science"},{"key":"ref257","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00097","article-title":"A New Classification System for IgG4 Autoantibodies","volume":"9","author":"Koneczny I","year":"2018","unstructured":"Koneczny I. A New Classification System for IgG4 Autoantibodies. Front Immunol. 2018, 9:97. 10.3389\/fimmu.2018.00097","journal-title":"Front Immunol"},{"key":"ref258","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1032909","article-title":"The clinical significance of allergen-specific IgG4 in allergic diseases","volume":"13","author":"Qin L","year":"2022","unstructured":"Qin L, Tang LF, Cheng L, Wang HY. The clinical significance of allergen-specific IgG4 in allergic diseases. Front Immunol. 2022, 13:1032909. 10.3389\/fimmu.2022.1032909","journal-title":"Front Immunol"},{"key":"ref259","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14023","article-title":"Hypersensitivity may be involved in severe COVID-19","volume":"52","author":"Tan C","year":"2022","unstructured":"Tan C, Zheng X, Sun F, et al.. Hypersensitivity may be involved in severe COVID-19. Clin Exp Allergy. 2022, 52:324-33. 10.1111\/cea.14023","journal-title":"Clin Exp Allergy"},{"key":"ref260","doi-asserted-by":"publisher","DOI":"10.3390\/biom13091338","article-title":"Does SARS-CoV-2 induce IgG4 synthesis to evade the immune system?","volume":"13","author":"Rubio-Casillas A","year":"2023","unstructured":"Rubio-Casillas A, Redwan EM, Uversky VN. Does SARS-CoV-2 induce IgG4 synthesis to evade the immune system?. Biomolecules. 2023, 13:10.3390\/biom13091338","journal-title":"Biomolecules"},{"key":"ref261","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40103-x","article-title":"Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history","volume":"13","author":"Kiszel P","year":"2023","unstructured":"Kiszel P, S\u00edk P, Mikl\u00f3s J, Kajd\u00e1csi E, Sinkovits G, Cervenak L, Proh\u00e1szka Z. Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history. Sci Rep. 2023, 13:13166. 10.1038\/s41598-023-40103-x","journal-title":"Sci Rep"},{"key":"ref262","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.11.028","article-title":"The appearance of anti-spike receptor binding domain immunoglobulin G4 responses after repetitive immunization with messenger RNA-based COVID-19 vaccines","volume":"139","author":"Yoshimura M","year":"2024","unstructured":"Yoshimura M, Sakamoto A, Ozuru R, et al.. The appearance of anti-spike receptor binding domain immunoglobulin G4 responses after repetitive immunization with messenger RNA-based COVID-19 vaccines. Int J Infect Dis. 2024, 139:1-5. 10.1016\/j.ijid.2023.11.028","journal-title":"Int J Infect Dis"},{"key":"ref263","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1325243","article-title":"Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19","volume":"15","author":"Adhikari B","year":"2024","unstructured":"Adhikari B, Bednash JS, Horowitz JC, Rubinstein MP, Vlasova AN. Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19. Front Immunol. 2024, 15:1325243. 10.3389\/fimmu.2024.1325243","journal-title":"Front Immunol"},{"key":"ref264","doi-asserted-by":"publisher","DOI":"10.3390\/cells9091975","article-title":"SARS-CoV-2 Spike 1 protein controls natural killer cell activation via the HLA-E\/NKG2A pathway","volume":"9","author":"Bortolotti D","year":"2020","unstructured":"Bortolotti D, Gentili V, Rizzo S, Rotola A, Rizzo R. SARS-CoV-2 Spike 1 protein controls natural killer cell activation via the HLA-E\/NKG2A pathway. Cells. 2020, 9:10.3390\/cells9091975","journal-title":"Cells"},{"key":"ref265","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating Spike protein detected in post-COVID-19 mRNA vaccine myocarditis","volume":"147","author":"Yonker LM","year":"2023","unstructured":"Yonker LM, Swank Z, Bartsch YC, et al.. Circulating Spike protein detected in post-COVID-19 mRNA vaccine myocarditis. Circulation. 2023, 147:867-76. 10.1161\/CIRCULATIONAHA.122.061025","journal-title":"Circulation"},{"key":"ref266","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab465","article-title":"Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients","volume":"74","author":"Ogata AF","year":"2022","unstructured":"Ogata AF, Cheng CA, Desjardins M, et al.. Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients. Clin Infect Dis. 2022, 74:715-8. 10.1093\/cid\/ciab465","journal-title":"Clin Infect Dis"},{"key":"ref267","doi-asserted-by":"publisher","DOI":"10.1002\/prca.202300048","article-title":"Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: possible molecular mechanisms","volume":"17","author":"Brogna C","year":"2023","unstructured":"Brogna C, Cristoni S, Marino G, et al.. Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: possible molecular mechanisms. Proteomics Clin Appl. 2023, 17:e2300048. 10.1002\/prca.202300048","journal-title":"Proteomics Clin Appl"},{"key":"ref268","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry EJ","year":"2003","unstructured":"Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003, 77:4911-27. 10.1128\/jvi.77.8.4911-4927.2003","journal-title":"J Virol"},{"key":"ref269","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050100","article-title":"Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells","volume":"5","author":"Streeck H","year":"2008","unstructured":"Streeck H, Brumme ZL, Anastario M, et al.. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med. 2008, 5:e100. 10.1371\/journal.pmed.0050100","journal-title":"PLoS Med"},{"key":"ref270","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0800997","article-title":"Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion","volume":"182","author":"Bucks CM","year":"2009","unstructured":"Bucks CM, Norton JA, Boesteanu AC, Mueller YM, Katsikis PD. Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion. J Immunol. 2009, 182:6697-708. 10.4049\/jimmunol.0800997","journal-title":"J Immunol"},{"key":"ref271","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2022.0002","article-title":"Dysfunctional state of T cells or exhaustion during chronic viral infections and COVID-19: a review","volume":"35","author":"Mishra KP","year":"2022","unstructured":"Mishra KP, Singh M, Saraswat D, Ganju L, Varshney R. Dysfunctional state of T cells or exhaustion during chronic viral infections and COVID-19: a review. Viral Immunol. 2022, 35:284-90. 10.1089\/vim.2022.0002","journal-title":"Viral Immunol"},{"key":"ref272","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00856-w","article-title":"A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)","volume":"20","author":"Mohammed RN","year":"2022","unstructured":"Mohammed RN, Tamjidifar R, Rahman HS, et al.. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Commun Signal. 2022, 20:79. 10.1186\/s12964-022-00856-w","journal-title":"Cell Commun Signal"},{"key":"ref273","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1777911\/v1","article-title":"Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients [PREPRINT]","author":"Benitez Fuentes JD","year":"2022","unstructured":"Benitez Fuentes JD, Mohamad KM, de Luna Aguilar A, et al.. Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients [PREPRINT]. Res Sq. 2022, 10.21203\/rs.3.rs-1777911\/v1","journal-title":"Res Sq"},{"key":"ref274","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn SD","year":"2009","unstructured":"Blackburn SD, Shin H, Haining WN, et al.. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 2009, 10:29-37. 10.1038\/ni.1679","journal-title":"Nat Immunol"},{"key":"ref275","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry EJ","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015, 15:486-99. 10.1038\/nri3862","journal-title":"Nat Rev Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/218170-impacts-of-the-sars-cov-2-spike-protein-on-the-innate-immune-system-a-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T06:31:43Z","timestamp":1711521103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/218170-impacts-of-the-sars-cov-2-spike-protein-on-the-innate-immune-system-a-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":275,"URL":"https:\/\/doi.org\/10.7759\/cureus.57008","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}